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Drinking water utilities reliant on surface water utilize chemically-assisted filtration (CAF) as a 
key barrier against the passage of protozoan pathogens, like Cryptosporidium spp. oocysts, to 
treated water. The goal of this work was to enable system-specific and potentially dynamic 
assessment of oocyst removal by CAF by using zeta potential as a tool for rapid operational 
feedback. Specifically, this work focused on systems utilizing high quality, low turbidity (typically 
<1 NTU) source water, with relatively low C. parvum oocyst concentrations and applied full scale 
coagulant doses (typically <5 mg/L). In these systems, the formation of settleable flocs is not a 
necessity because source water turbidities are already low and frequently meet treated water 
criteria. Rather, coagulation is used to enable particle removal through physico-chemical (i.e., 
chemically -assisted) filtration, as indicated by filter effluent turbidities that may or may not be 
indicative of optimal particle destabilization and removal by CAF. Accordingly, the identification 
of “optimal” coagulant doses can be challenging, and becomes even more challenging when 
process performance is being assessed, such as when Cryptosporidium oocysts are added to filter 
influents to evaluate their removal by CAF processes.  
In Phase 1 of this work, the role of oocyst coagulation during CAF performance demonstrations 
was investigated. It was demonstrated that appropriate coagulation of oocyst seed suspensions is 
critical to reflecting “well-operated” CAF performance. A protocol for ensuring optimal 
coagulation of oocyst seed suspensions during such performance demonstrations was developed 
and demonstrated at pilot-scale. Here, zeta potential was useful in identifying the coagulant doses 
needed for maximal particle destabilization and removal by CAF. This pilot-scale approach was 
then validated using lower, environmentally relevant oocyst concentrations (and much longer 
pilot-scale investigations) during which the entire filtered volume of water was evaluated. Using 
this protocol, it was demonstrated that a minimum of 3-log oocyst removal could be achieved by 
CAF (essentially direct filtration) at a variety of operational conditions.  
During Phase 2 of this work, the protocol developed in Phase 1 was used to evaluate oocyst passage 
through CAF processes with different filter designs (bed depths, water temperature) at various 
operational conditions (suboptimal coagulation, filter ripening, end-of-run operation, and 
hydraulic surges). Here, because of the high quality, low turbidity source water, adequate 
coagulation was the dominant control for risk, in contrast to many reported investigations in which 
more deteriorated source water was investigated and operational period within the filter cycle was 
a more dominant control over oocyst passage through the CAF process. Here, with the exception 
of suboptimal coagulation conditions, the pilot-scale filters consistently achieved >3-log C. 
parvum oocyst removal in an essentially directly filtration mode. Thus, this work demonstrated 
the critical importance of (1) appropriate particle destabilization by coagulation prior to CAF of 
low turbidity, low DOC source waters, (2) coagulation of oocysts prior to their addition to filter 
influent streams during CAF performance demonstrations, and (3) zeta potential as a useful tool 
for ensuring adequate particle destabilization in situations (i.e. treatment of low turbidity, low 
DOC source waters) in which extensive particle settling is not likely. In doing so, this work further 
highlights that Cryptosporidium spp. oocyst removal credits of >2.5 log may be warranted for 
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Chapter 1 Introduction 
Protozoan pathogens, especially Cryptosporidium spp., are a key driver of drinking water 
treatment infrastructure needs in North America. It has been estimated that these pathogens 
recently cost employers ~$10 million over a three-month period in at least one jurisdiction  
(Ridderstedt, Widerström, Lindh, & Lilja, 2017). Climate change is expected to exacerbate these 
risks due to increased frequency and intensity of extreme weather events, which have been linked 
to increased protozoan pathogen occurrence in source waters (Davies et al., 2004). Most drinking 
water utilities reliant on surface water in North America utilize chemically-assisted filtration 
(CAF) as a key barrier against the passage of protozoan pathogens into treated drinking water. 
Although UV irradiation offers an effective alternative to traditional disinfectants, it is 
significantly more expensive than widely used chlorination in both capital and operations and 
maintenance costs (Snicer, Malley, Margolin, & Hogan, 2000); thus, CAF remains a critical and 
required (MOEE, 2000; USEPA, 2006b) drinking water treatment process for managing protozoan 
pathogen health risks (Emelko, Huck, & Coffey, 2005; Ramsay, Wagner, Robertson, Smith, & 
Pollock, 2014).  
Current regulations are treatment technique-driven and have necessitated performance 
demonstrations to quantify oocyst removal by specific treatment configurations or facilities. 
Performance demonstrations typically require sufficiently high initial concentrations of 
Cryptosporidium oocysts to enable calculation of their removal by treatment processes; thus, 
oocysts are often added to process influent streams and performance is assessed by evaluating the 
difference between influent and effluent concentrations, typically on a log basis. The majority 
reported demonstrations of Cryptosporidium oocyst removal by CAF have focused on systems 
treating relatively more deteriorated source water quality (Dugan, Fox, Owens, & Miltner, 2001; 
Emelko, 2003; Emelko, Huck, & Douglas, 2003; Huck, Coffey, Emelko, et al., 2002; Nieminski 
& Ongerth, 1995), rather than those treating high quality (defined herein as low turbidity [on 
average values are between 0.5 and 3.0 NTU] and low total organic carbon (TOC) [<2 mg/L]) 
source/raw water.  
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Systems treating high quality source water from surface-based sources often face unique 
operational challenges associated with coagulation. Conventional CAF comprised of coagulation, 
flocculation, and sedimentation if often employed in surface water treatment to receive 3-log 
credits for the treatment of Cryptosporidium spp. and Giardia spp. (USEPA, 1999). In these 
systems, the formation of settleable flocs is not a necessity, however, because source water 
turbidities are already low and frequently meet treated water criteria. Rather, coagulation is used 
to enable particle removal through physico-chemical (i.e., chemically -assisted) filtration, as 
indicated by filter effluent turbidities that may or may not be indicative of optimal particle 
destabilization and removal by CAF. Accordingly, the identification of “optimal” coagulant doses 
can be challenging, and becomes even more challenging when process performance is being 
assessed, such as when Cryptosporidium oocysts are added to filter influents to evaluate their 
removal by CAF processes.  
1.1 Research Objectives 
Information regarding Cryptosporidium oocyst removal by CAF is relatively scant for treatment 
systems in which low turbidity, low DOC source waters are typically treated by sweep floc 
coagulation prior to CAF. This information is critical because treatment performance in these high 
quality systems is likely the most vulnerable to relatively small shifts in source water quality and/or 
periods of non-ideal operation challenges (e.g., hydraulic surges) because of the associated need 
to rapidly adjust coagulant dosing. Accordingly, the overall goal of this research was to gain a 
better understanding of protozoan pathogen removal by CAF in systems treating low turbidity, low 
dissolved organic carbon (DOC) source water and to provide strategies for better treatment process 
evaluations and control. With specific application to low turbidity, low DOC source water, the 
specific objectives of this work were to: 
1. Quantitatively evaluate Cryptosporidium parvum (C. parvum) oocyst removal by CAF; 
2. Develop a protocol for conducting CAF performance demonstrations in which high 
concentrations of (oo)cysts are introduced to CAF influent streams to (a) enable 




3. Evaluate filter design (depth) and operational (sub-optimal coagulation, ripening, hydraulic 
surges, etc.) effects on C. parvum oocyst passage through CAF to identify key process 
controls for ensuring optimal performance; 
4. Evaluate the adequacy of support infrastructure/tools (i.e., turbidity, zeta potential analysis) 
for ensuring adequate protozoan pathogen removal by CAF in near-real-time; and, 
5. Assess the validity of utilizing high oocyst concentrations in filtration performance 
demonstrations to quantify the removal of lower/more environmentally relevant oocyst 
concentrations by CAF. 
1.2 Research Approach  
While C. parvum oocyst removal by CAF has been widely investigated, very few studies have 
evaluated it in plants treating low turbidity and low DOC source water. To address this important 
knowledge gap, a two phase research program was devised to (1) develop strategies for conducted 
performance demonstrations in systems treating this type of source water and (2) evaluate design 
and operational effects on oocyst passage through CAF processes. 
Phase 1 involved the development and validation of a seeding protocol in which Cryptosporidium 
oocysts could be added to the influent stream pilot-scale CAF processes to evaluate their removal 
in a manner reflecting optimal, “well operated” treatment of low turbidity, low DOC source water. 
To do this, a jar coagulation investigation was conducted to monitor turbidity and zeta potential 
during incremental additions of coagulant, aluminum sulfate (alum), to establish optimal particle 
destabilization and the coagulant dose required to achieve it. This test was followed by a series of 
pilot-scale CAF tests in which the dominant mechanisms of coagulation were investigated to 
validate the seeding protocol. To further validate the seeding protocol, a set of more 
environmentally relevant oocyst concentrations were seeded into the pilot filters over a longer 
duration using the Environmental Protection Agency (EPA) Method 1623 (USEPA, 2005). The 
development of this seeding protocol was critical to establishing the conditions under which pilot-
scale CAF operation in an essentially direct filtration mode could be considered “well-operated”. 
This protocol—and the capacity to identify appropriate particle (and oocyst) destabilization—was 
critical given that oocysts were being added to a low turbidity, low DOC source water, thereby 
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changing water quality substantially in most cases and potentially necessitating shifts in coagulant 
dosing for adequate particle destabilization.   
During Phase 2, the oocyst seeding protocol developed during Phase 1 was used to evaluate oocyst 
passage through CAF processes with different filter designs (bed depths, water temperature) at 
various operational conditions (suboptimal coagulation, filter ripening, end-of-run operation, and 
hydraulic surges). During this phase, zeta potential analysis was further explored as a tool for 
ensuring optimal particle destabilization and oocyst removal during CAF.  
1.3 Thesis Structure 
The remainder of the thesis is divided into four chapters, a reference list, and a series of appendices. 
Chapter 2 provides background information related to the research objectives. It largely focuses 
on past research related to Cryptosporidium spp. oocyst removal by CAF. Following this, Chapter 
3, outlines the general research approach including experimental development and rationale. The 
various methods used throughout the research and their development are described. Chapter 4 




Chapter 2 Background 
2.1 Cryptosporidium spp. 
Although Cryptosporidium spp. oocysts were first described in the early 1900’s, cryptosporidiosis 
in humans was reported for the first time in the 1970’s (Fayer, 1997). Since then, seventeen species 
of Cryptosporidium have been identified in humans worldwide; the most common species reported 
in humans are C. parvum, and C. hominis (Zahedi, Paparini, Jian, Robertson, & Ryan, 2016). 
While C. parvum infects a wide range of host species, C. hominis only infects humans (Zahedi et 
al., 2016). Cryptosporidium exists in two forms, the infectious stage inside a host and in an 
environmentally resistant stage known as an oocyst (i.e. the stage that is of interest to drinking 
water providers). Regardless of the species, oocysts are generally 4 to 6 μm in diameter and have 
a relatively low infectious dose that is believed to range from 10 to 30 oocysts (CDC, 2005).  
2.1.1 Sources and Outbreaks of Waterborne Diseases 
Outbreaks of cryptosporidiosis continue to occur globally (Baldursson & Karanis, 2011; 
Efstratiou, Ongerth, & Karanis, 2017; Karanis, Kourenti, & Smith, 2007) and have been reported 
in over 90 countries and on all continents populated by humans (Dillingham, Lima, & Guerrant, 
2002; Fayer, Morgan, & Upton, 2000). Notably, the largest cryptosporidiosis outbreak in U.S. 
history occurred in 1993, in Milwaukee, WI affecting 25% of the population (406,000 individuals). 
In Canada, the largest recorded outbreak occurred in Kitchener-Waterloo, ON with 23,900 
reported cases of cryptosporidiosis; remarkably, this outbreak occurred with no evidence of 
compromised treatment (Welker et al., 1994).  
Prior to 2007, 325 water-associated outbreaks of cryptosporidiosis had been reported; the majority 
of these occurred in North America and Europe (Karanis et al., 2007). This is likely because more 
cases go unreported or misdiagnosed in jurisdiction with limited financial resources. Mahmoudi 
et al. (2017) reported on the prevalence of Cryptosporidium spp. occurrence and cryptosporidiosis 
in Asia, which experienced similar occurrences to other continents. Human infectious 
Cryptosporidium spp. are ubiquitous and increasingly being reported in jurisdictions outside of 
North America and Europe, underscoring the global need to identify strategies for protecting 
public health from associated outbreaks of waterborne disease.  
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2.1.1.1 Outbreaks of Waterborne Disease and Associated Implications for Society 
Recently, drinking water outbreaks of disease in Europe, North America, and New Zealand from 
2000 to 2014 were reviewed, confirming that the waterborne pathogenic protozoa 
Cryptosporidium spp. and Giardia spp. still pose a significant health risk, affecting more 
consumers than other pathogens; and underscoring that surface water supply contamination 
remains the leading cause of exposure (Moreira & Bondelind, 2017). Nonetheless, holistic 
assessments of the societal implications and costs of outbreaks of waterborne diseases such as 
cryptosporidiosis are relatively scant, though there are a few notable exceptions. A few of these 
key case studies are discussed below. 
The well-known, 1993 Milwaukee cryptosporidiosis outbreak affected a very large number of 
individuals; specifically, approximately 403,000 of the 1.61 million residents who lived in the city 
(Davis et al., 1994) were affected by this outbreak. In this case, the source of this outbreak was a 
deficiency in one of the two drinking water treatment facilities in which CAF treatment 
performance was  inadequate, thereby resulting in Cryptosporidium oocyst passage into the treated 
drinking water supply (Davis et al., 1994). Corso et al. (2003) reported losses due to medical 
expenses and non-medical expenses (productivity losses) after this outbreak; costs due to litigation, 
bottled water purchases, and government involvement were included in that assessment. 
Specifically, they concluded that the total cost of medical care and productivity losses resulting 
from the outbreak was approximately $96.2 million (USD), based on $31.7 million in medical 
costs and $64.6 million in productivity losses (i.e., 67% of the total cost of the outbreak). Notably, 
although only 1% of those infected had severe cases of disease that required hospitalization, these 
cases accounted for 74% of the total medical costs. 
A recent retrospective study in Sweden demonstrated that cryptosporidiosis-related absences from 
work per sick child shared between parents/guardians over a three-month period in 2010 resulted 
in an estimated direct cost of €7 million (~$10 million CDN) for employers (Ridderstedt et al., 
2017). This assessment accounted for adults who took sick leave due to their own symptoms as 
well as those who took sick leave to care for children. Notably, adults who took sick days to care 
for sick children accounted for 25% of the sick days taken by working adults. It was estimated that 
45% of the population of 60,000 was affected by an outbreak of Cryptosporidium hominis 
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(Widerström et al., 2014). Here, young age, number of infected family members, amount of water 
consumed daily, and gluten intolerance were identified as key risk factors associated with illness; 
importantly, insufficient drinking water treatment was implicated in this outbreak of waterborne 
disease. The implication of drinking water treatment here further underscores the importance of 
ensuring that assessments that conclude that “well-operated” drinking water treatment is being 
practiced, and adequately reflects adequate particle (and therefore protozoan pathogen) 
destabilization for effect removal during CAF treatment when these widely-implemented 
processes are implemented.  
Unlike other earlier economic analyses of large cryptosporidiosis outbreaks, Chyzheuskaya et al. 
(2017) included a multitude of costs from both the private and public sectors from the 
cryptosporidiosis outbreak in Galway, Ireland. This study included costs that are a direct impact 
from the 242 confirmed cases and includes costs faced by other groups like those in the affected 
population from the surrounding area that had boiled water advisories over a 158 day period. The 
total cost of the Galway, Ireland outbreak exceeded €19 million (Chyzheuskaya et al., 2017). 
Finally, Adam et al. (2017) reported that in 2014 American insurance covered approximately $1 
million (USD) worth of expenses to treat cryptosporidiosis nationwide. The CDC (2010) reported 
that between 2004 and 2007, the annual cost for hospitalisations in the U.S. caused by 
cryptosporidiosis totalled $37-145 million. This estimate included the administrative cost to the 
U.S. government through the delivery of programs like Medicare and Medicaid. These reports 
underscore that waterborne disease attributable to pathogenic protozoa, and cryptosporidiosis 
specifically, remains a persistent, 21st century threat to public health that drives the need for a 
better understanding of treatment options and real- or near-real-time assessments of treatment 
performance in managing these risks.  
2.2 Regulatory Policy Approaches to Managing Risks of Waterborne Diseases 
Attributable to Cryptosporidium spp. 
Given the health effects associated with exposure to pathogenic protozoa such as Cryptosporidium 
spp., health-based treatment goals of a minimum 3.0-log removal and/or inactivation of cysts and 
oocysts are typically implemented in Canada (Health Canada, 2012) and the United States 
(USEPA, 2006b), as well as other jurisdictions (MOECC, 2016). In general, source water quality 
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is characterized and then pathogen removal/treatment targets are established to achieve safe 
finished drinking water quality. Risk assessment approaches that rely upon concepts of maximum 
acceptable risk levels have been developed to manage these risks (Health Canada, 2012; USEPA, 
2006b). Although quite variable across different jurisdictions for ground water supplies, regulatory 
policy approaches to managing risks of waterborne diseases attributable to pathogenic protozoa 
such as Cryptosporidium spp. in surface water supplies are generally similar across jurisdictions, 
especially Canada and the United States.  
In general, risks to public health attributable to waterborne pathogens in surface water-based 
drinking water supplies are managed using a combination of treatment strategies; specifically, 
pathogen removal by physico-chemical treatment processes and inactivation by disinfection 
processes (Health Canada, 2012; USEPA, 2006b). Further protection of public health from 
waterborne bacteria and viruses (but not protozoa) is achieved by maintaining an adequate 
concentration of disinfectant residual throughout the distribution system (Health Canada, 2012; 
USEPA, 2006b). Although UV irradiation offers effective disinfection of protozoa, it is 
significantly more expensive in both capital and operations and maintenance costs than widely 
used chlorination (Snicer et al., 2000); moreover, most surface waters also require removal of 
turbidity/suspended solids for efficient implementation of disinfection; thus, CAF remains a 
critical and required (MOEE, 2000; USEPA, 2006a) barrier to protozoan pathogen passage into 
treated drinking water supplies (Emelko et al., 2005; Ramsay et al., 2014). Accordingly, most 
drinking water utilities reliant on surface water in North America utilize CAF or equivalent 
treatment for managing Cryptosporidium spp. risks.  
Quantitative microbial risk assessment (QMRA) approaches have been developed to better manage 
these risks, and although they are increasingly used, they are also continuously evolving (Health 
Canada, 2012; Schmidt & Emelko, 2011). In Canada and the United States, risks from 
Cryptosporidium spp. (and other pathogens) are managed and regulated using a “treatment 
technique” based approach in which oocyst treatment (i.e., removal or disinfection) credits are 
allocated for implementation of specific treatment infrastructure and evidence of “well-operated” 
treatment (e.g., achieving specified treated water quality targets). These frameworks rely on the 
identification of critical control points that represent a point, step, or procedure at which control 
can be applied and, as a result, a water safety hazard can be prevented, eliminated, or reduced to 
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an acceptable level (WHO, 2017). Although an exhaustive review of these continuously evolving 
frameworks and the associated regulatory policies is beyond the scope of the present investigation, 
a brief overview of Canadian and U.S. regulatory policies and associated guidelines is provided 
below. 
2.3 Regulatory Framework in North America for Managing Waterborne Diseases  
The need for approaches that deliver reliable quantitative data that are representative of full-scale 
Cryptosporidium oocyst removal through CAF treatment processes is rooted in American and 
Canadian regulatory frameworks focused on protecting public health by ensuring adequately 
removal of protozoan pathogens during drinking water treatment using a treatment technique-
based approach, rather than requiring cost-prohibitive monitoring. These frameworks are 
discussed in brief below.  
2.3.1 Canadian Federal Guidelines 
Health Canada publishes the Guidelines for Canadian Drinking Water Quality, which are reviewed 
on a regular basis. The guidance document entitled “Enteric Protozoa: Giardia and 
Cryptosporidium” is a component of those guidelines (Health Canada, 2012). It discusses and 
details treatment technique driven approaches for managing risks of waterborne diseases 
attributable to pathogens. As mentioned above, treatment credits awarded for implementation of 
specific treatment infrastructure and evidence of “well-operated” treatment (e.g., achieving 
specified treated water quality targets). Different process configurations receive different 
treatment credits that are prescribed based on general consensus of the research and practitioner 
communities; thus, an expert-system type of approach is utilized. For example, for the treatment 
of Cryptosporidium spp., “well operated” conventional treatment (i.e., coagulation, flocculation, 
and clarification followed by CAF) receives 3-log (99.9% removal) treatment credit, whereas 
direct filtration (i.e., only coagulation and flocculation followed by CAF) receives only 2.5-log 
(99.7% removal) treatment credit.  
Oocyst (and cyst) removal requirements are based on the source water quality; as source water 
oocyst concentrations increase beyond 10 oocysts/100 L (on a log scale), the required levels of 
treatment increases proportionally (Health Canada, 2017). Importantly, the treatment credits 
assigned to CAF filtration processes are largely based on pilot- and full-scale performance 
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demonstrations reported in the 1990’s and early 2000’s in which highly variable oocyst 
concentration, purification, and enumeration techniques were used, and often poor surrogate 
parameters were relied upon to avoid expensive and laborious enumeration of oocysts (Dugan et 
al., 2001; Dugan & Williams, 2004; Emelko, 2003; Emelko et al., 2005, 2003; Huck, Coffey, 
Anderson, et al., 2002; Huck, Coffey, Emelko, et al., 2002; Nieminski & Ongerth, 1995; Ongerth 
& Pecoraro, 1995; Xagoraraki, Harrington, Assavasilavasukul, & Standridge, 2004a). If required, 
additional credits can be achieved by reaching specific treated water quality targets (e.g., 0.1 NTU 
95th percentile turbidity in combined filter effluents) beyond those that are required (e.g., 
maximum combined filter effluent turbidity for conventional and direct filtration cannot exceed 
0.3 NTU in at least 95% of measurements collected in any given month, with no one measurement 
exceeding 1 NTU [Health Canada, 2017]) or implementation of additional disinfection processes 
such as UV irradiation (Health Canada, 2012).  
2.3.2 Ontario Provincial Regulations 
In Ontario, regulatory requirements for Cryptosporidium spp. oocyst removal and disinfection are 
described in the Procedure for Disinfection of Drinking Water in Ontario (MOECC, 2016). 
Consistent with the federal guidelines, the province of Ontario uses a removal-based credit system 
to evaluate drinking water treatment compliance in achieving public health protection goals 
associated with managing health risks attributable to waterborne Cryptosporidium spp. It should 
be highlighted that Ontario is the only province in Canada that deviates from Health Canada’s 
recommended guideline of achieving a minimum of 3-log treatment of both Cryptosporidium spp. 
and Giardia spp. for conventional filtration (Health Canada, 2017). While Ontario uses this same 
framework for Giardia spp., a minimum of only 2-log treatment is required for Cryptosporidium 
spp.; consistent with this, well-operated conventional CAF processes are only awarded 2-log 
treatment credit (MOECC, 2016). Direct filtration is also awarded 2-log treatment credit by the 
provincial regulation. The policies specify that treatment (i.e., removal and/or disinfection) 
requirements may be increased in situations of “higher than typical” source water oocyst or cyst 
concentrations; for example, in the case of intakes that are exposed to agricultural runoff or 
wastewater treatment plant discharges (MOECC, 2016). 
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2.3.3 U.S. Policies 
In December 1998, the United States Environmental Agency (USEPA) finalized the Interim 
Enhanced Surface Water Treatment Rule (IESWTR) that set Cryptosporidium treatment standards 
(USEPA, 1999). To limit public exposure to pathogenic protozoa in treated drinking water, the 
Rule outlined a maximum contaminant level goal of zero Cryptosporidium oocysts and a minimum 
of 2-log oocyst removal to be achieved by CAF processes. To receive this 2-log treatment credit, 
the maximum combined filter effluent turbidity could not exceed 0.3 NTU in at least 95% of 
measurements collected in any given month, with no one measurement exceeding 1 NTU (USEPA, 
1999). 
In January 2002, the USEPA released the  Long-Term 1 Enhanced Surface Water Treatment Rule 
(LT1ESWTR). This was created to supplement the IESWTR by focusing on public water systems 
serving fewer than 10,000 persons, which were previously not regulated under the SWTR (which 
addressed only on Giardia spp. and preceded the IESWTR). The LT2ESWTR was enacted in 2006 
to address risks from Cryptosporidium spp. and provide greater clarity in defining higher risk 
systems and associated treatment requirements (i.e., required treatment credits) and identifying 
approaches for achieving additional treatment credits. The LT2ESWTR relied upon source water 
Cryptosporidium spp. monitoring that was required as part of the 2001 Information Collection 
Rule (USEPA, 2001) to identify whether or not additional treatment of Cryptosporidium spp. was 
required. A “bin” approach was developed; it is presented in Table 2-1 and Table 2-2. Similar to 
the Canadian guidelines and regulations developed by Health Canada (Health Canada, 2017), 
higher source water concentrations of Cryptosporidium spp. require more extensive treatment. 
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 Table 2-1. Bin Classification System used by the USEPA in the LT2ESWTR (USEPA, 2006a) 
For systems that are: Mean Cryptosporidium 
Concentration* 
Bin Classification 
…required to monitor for 
Cryptosporidium 
< 0.075 oocysts/L Bin 1 
From 0.075 to 1.0 oocysts/L Bin 2 
From 1.0 to 3.0 oocysts/L Bin 3 
≥ 3.0 oocysts/L Bin 4 
     *Samples must be analyzed by an approved laboratory and use USEPA Method 1622 or 1623
 
Table 2-2. Additional Treatment Requirements for Filtered Systems used by the USEPA in the 
LT2ESWTR (USEPA, 2006a) 
 
If the system uses the following filtration in full compliance with existing 






















Bin 2 1-log treatment 1.5-log treatment 1-log treatment (1) 
Bin 3 2-log treatment 2.5-log treatment 2-log treatment (2) 
Bin 4 2.5-log treatment 3-log treatment 2.5-log treatment (3) 
(1) As determined by the state such that the total Cryptosporidium removal and inactivation is at least 4.0-log 
(2) As determined by the state such that the total Cryptosporidium removal and inactivation is at least 5.0-log 
(3) As determined by the state such that the total Cryptosporidium removal and inactivation is at least 5.5-log 
2.3.3.1  Standardized Methods of Cryptosporidium spp. Detection 
Analytical methods for quantification of Cryptosporidium spp. oocysts from water were originally 
developed from those for Giardia spp.; to date, they remain unreliable (i.e. with widely variable 
recovery), laborious, and expensive. In brief, these methods typically require three steps: 
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concentration, purification, and enumeration. In 1999, USEPA Method 1623 was published to 
serve as a standard method for enumerating Cryptosporidium spp. and Giardia spp. in natural 
waters (USEPA, 2005). In brief, it involves filtration of relatively large volumes of water, 
immunomagnetic separation, an immunofluorescence assay (IFA) for identification, and manual 
enumeration using fluorescence microscopy. Quintero-Betancourt et al. (2002) reviewed 
laboratory methods for detection and enumeration of Cryptosporidium spp. oocysts and noted that 
the method recovery efficiency ranges from 12-93%, which generally falls within the 21-100% 
range specified within USEPA’s acceptance criteria (USEPA, 2005). However, other techniques 
that involve filtration of smaller sample volumes directly on membrane filters, IFA, and direct 
enumeration using epifluorescence microscopy have been widely used in performance 
demonstrations (Emelko et al., 2003; Hansen & Ongerth, 1991; Huck, Coffey, Emelko, et al., 
2002; Lalancette, Di Giovanni, & Prévost, 2010; Rochelle, Johnson, Leon, & Di Giovanni, 2012). 
The sample volumes processed using these methods can be orders of magnitude smaller than those 
processed using standard methods such USEPA Method 1623.1 (USEPA, 2005) thereby allowing 
for more samples to be processed in a shorter amount of time. Importantly, for pilot-scale 
performance demonstrations in which large numbers of oocysts are added to treatment process 
influent streams, more expensive methods developed to enable the processing of large sample 
volumes (e.g. Method 1623.1) are not needed.  
2.4 Drinking Water Treatment  
Many aspects of drinking water source quality affect treatment design and operations; these 
include alkalinity, pH, turbidity, natural organic matter (NOM; typically described by total organic 
carbon (TOC) or dissolved organic carbon (DOC), temperature, colour, and hardness (Crittenden, 
Trussell, Hand, Howe, & Tchobanoglous, 2012; Edzwald, 2011). It is important to note, however, 
that turbidity, an indicator of suspended solids, and NOM are the two main aspects of water quality 
that govern the need to implement certain treatment infrastructure; specifically, CAF or equivalent 
treatment processes (Crittenden et al., 2012; Edzwald, 1993; Pernitsky & Edzwald, 2006; Van 
Benschoten & Edzwald, 1990). Critically, aromatic fractions of NOM exert greater coagulant 
demand than less aromatic or non-aromatic fractions (Crittenden et al., 2012; Edzwald, 2011).  
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As landscapes change, whether from urban landscape developments, changing industrial practices, 
or climate change-associated disturbances (e.g., floods, wildfires), source water quality 
deteriorates, and turbidity and NOM levels are increasingly elevated and more variable (Tufenkji 
& Emelko, 2011). Thus, source water protection and implementation of resilient water treatment 
infrastructure and operations are increasingly imperative. These challenges underscore the need to 
develop tools to better signal periods of higher/lower risk during the provision of potable water, 
thereby enabling operator responsiveness, more resilient treatment, and enhanced protection of 
public health. Important aspects of drinking water treatment that affect the removal of particles, 
and more specifically pathogens are discussed below, especially as they relate to treatment of high 
quality (low turbidity, low DOC) source water supplies. Finally, key knowledge gaps are 
highlighted and opportunities to address these gaps are identified—these form the rationale for the 
research reported in this thesis. 
2.4.1 Coagulation Regimes and Physico-chemical Filtration 
Coagulation is a vital component of conventional drinking water treatment and has been widely 
identified as an integral contributor to Cryptosporidium parvum oocyst removal by CAF (Barkay-
Arbel et al., 2012; Brown & Emelko, 2009; Dai & Hozalski, 2002; James K. Edzwald & Kelley, 
1998; Emelko, 2003; Huck et al., 2002; Keegan et al., 2008; Logsdon, 2000; Nieminski & Ongerth, 
1995; Ongerth & Pecoraro, 1995; Shaw et al., 2000; Torabian et al., 2008). There are two primary 
mechanisms of metal salt (e.g., aluminum sulfate [alum], ferric chloride, etc.) coagulation: 
(1) adsorption and charge neutralization and (2) sweep coagulation (Amirtharajah & Mills, 1982; 
Lartiges et al., 1997). As described by Pernitsky & Edzwald (2006) and Benjamin & Lawler 
(2012), colloids and nanoparticles are destabilized by stoichiometric adsorption of charged 
chemical species (e.g., hydrolyzed species of Al(III) and Fe(III)) that carry a charge opposite to 
that of the surface of the particle (which is typically negative in natural waters), thereby reducing 
the surface potential (decreasing repulsion forces) and neutralizing the surface charge. Thus, an 
overdose of adsorbable species can cause reversal of charge on the particle. In contrast, sweep 
coagulation involves precipitation of metal hydroxides and enmeshment of particles in those 
precipitates. In source waters containing low solids concentration, these precipitates also increase 
contact opportunities for flocculation and/or attachment to surfaces such as filter media. 
Amirtharajah & Mills (1982) analyzed numerous coagulation investigations and developed a 
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solubility diagram for aluminum hydroxide illustrates the regions of pH and alum dosage that 
correspond to the dominant mechanisms of alum coagulation—this figure is reproduced in Figure 
2-1 below. Johnson and Amirtharajah (1983) produced a similar diagram for ferric iron. 
 
The relevance of these mechanisms for achieving effective coagulation and physico-chemical 
filtration (i.e., CAF) has been widely reported (Bustamante, Shanker, Pashley, & Karaman, 2006; 
Butkus, Bays, & Labare, 2003; Ghernaout, 2015; Xagoraraki & Harrington, 2004). Indeed, these 
mechanisms enable physico-chemical filtration (which is not a size exclusion process) because 




















pH of Mixed Solution 
Figure 2-1. Design and operation diagram for alum coagulation (From Amirtharajah & 
Millls, Journal – American Water Works Association, Copyright © 1982 by John Wiley & 
Sons, Inc. Reprinted by permission of John Wiley & Sons, Inc.) 
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thermodynamically favorable for particle attachment on filter media surfaces. While these 
approaches offer a useful starting point for determining approximate coagulant dosages that result 
in different coagulation mechanisms at a given pH, it should be noted that humic and other organic 
substances (i.e., NOMs) can act as complexing ligands that can lead to higher concentrations of 
soluble aluminum complexes than those that would be predicted by theoretical solubility (Driscoll 
& Letterman, 1987).  
2.5 Surface Charge 
The surface charge of colloidal particles and surfaces is described by zeta potential, which is 
theoretically defined as “the difference in electric potential at the shear plane and the bulk liquid”. 
Zeta potential is not directly measured; rather, electrophoretic mobility is measured and zeta 
potential is back calculated using the Smoluchowski equation (McTigue & Symons, 2010): 
 𝐸𝑃𝑀 = (
𝜀𝜔
𝜇
) 𝜁 (1) 
in which EPM is the electrophoretic mobility, or the velocity of a particle excited by a known 
electric field (m/s), 𝜀𝜔 is the dielectric constant of water (F/m), 𝜇 is the dynamic viscosity of water 
(m2/s), and 𝜁 is the zeta potential (mV). As would be expected, alum concentration, zeta potential, 
and the removal of Cryptosporidium parvum oocyst (or any other particle) are inextricably linked 
(Bean et al., 1964; Cleasby et al., 1963; Gupta et al., 1973; Neuman, 1981; Riddick, 1961; 
Xagoraraki & Harrington, 2004). Of course, the proper interpretation of zeta potential data is 
critical (Neuman, 1981) and must be considered within the broader context of coagulation regime 
(discussed above) and its relationship to the treatment technology being deployed.  
As would be expected, optimal coagulation and CAF occur when negatively charged particles are 
destabilized such that the zeta potential remains negative and is within a few millivolts of the point 
of zero charge (PZC) (Bean et al., 1964; Bustamante et al., 2006; Cleasby et al., 1963; Ghernaout, 
2015; Gupta et al., 1973; Karaman, Pashley, Bustamante, & Shanker, 1999; Neuman, 1981; 
Riddick, 1961; Xagoraraki & Harrington, 2004; Xu, Fitzpatrick, & Deng, 2006). It has been 
suggested that ± 4 mV of the PZC is ideal (Xagoraraki & Harrington, 2004). Properly 
understanding the use of zeta potential was critical to interpreting and comparing results from this 
research by providing a range and understanding of zeta potential. 
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2.6 CAF Performance Demonstrations 
Performance demonstrations are conducted to quantitatively and reproducibly demonstrate 
pathogen removal achieved by treatment processes such as CAF. During these demonstrations, 
inactivated oocysts are added to unit process influent streams; this typically occurs at either the 
raw water or filter influent points within the treatment process. In some studies, oocyst seed 
suspensions were coagulated to destabilize the oocysts prior to their introduction to treatment 
process influent streams (Amburgey et al., 2005; Emelko, 2001, 2003, Emelko et al., 2005, 2003; 
Huck, Coffey, Anderson, et al., 2002; Huck, Coffey, Emelko, et al., 2002; Scott, 2008); in others, 
oocysts introduced to treatment process influent streams were not destabilized by coagulation 
(Dugan et al., 2001; Dugan & Williams, 2004; Nieminski & Ongerth, 1995; Ongerth & Pecoraro, 
1995; Swertfeger, Metz, DeMarco, Braghetta, & Jacangelo, 1999; Tomko & Scheuring, 2002; 
Xagoraraki, Harrington, Assavasilavasukul, & Standridge, 2004b). Notably, in most of the cases 
in which oocyst seed suspensions were not pre-coagulated prior to being introduced to treatment 
process influent streams, they were added prior to the coagulation stage of treatment; thus, they 
were coagulated during the process evaluations (Dugan et al., 2001; Dugan & Williams, 2004; 
Nieminski & Ongerth, 1995; Ongerth & Pecoraro, 1995; Swertfeger et al., 1999; Tomko & 
Scheuring, 2002; Xagoraraki et al., 2004b).  
The biggest challenge associated with conducting performance demonstrations in this latter 
manner is that they are often infeasible because of the high concentrations of oocysts introduced 
to the raw water in order to demonstrate >3-log removal of oocysts. This results in a sufficiently 
high, non-zero number of oocysts in the filter effluent stream (at least 10, as suggested by Emelko 
et al.,(2008)) so that treatment efficiency can actually be calculated without several orders of 
magnitude of uncertainty in the estimates. Moreover, this type of analysis would also require the 
analysis of very large volumes of filter effluent, likely hundreds to thousands of liters, depending 
on the type and scale of processes being evaluated. The direct addition of oocysts to filter influent 
streams enables these challenges to be avoided; however, this type of approach also requires 
appropriate oocyst destabilization. At present, no guidance for achieving oocyst destabilization in 
seed suspensions during such performance demonstrations is available. As discussed above, all of 
the performance demonstration reported in the literature to date have utilized full-scale plant 
coagulant doses in such cases. 
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2.7 High Quality Source Water  
Consistently “high quality” source water can be described as having low turbidity and low 
TOC/DOC; it is not typically influenced by seasonal fluctuations such as run-off of 
snowmelt/spring freshet. Plants that treat such source waters typically use low coagulant doses. 
"Low” turbidity source water is low in suspended solids and has been widely “defined” as 1 NTU 
or less (Al-Ani, Hendricks, Logsdon, & Hibler, 1986; Brink, Hendricks, & Al-Ani, 1988) though 
ranges of 0.5 to 5 NTU (Ongerth & Pecoraro, 1995) or 3 NTU or less (Bustamante et al., 2006) 
also have been suggested. Scott (2008) referred to low turbidity source water when using Lake 
Ontario water that averaged 0.29 NTU and ranged between 0.06 and 2.97 NTU—this is consistent 
with Masher & Hendricks (1986) whose source water turbidity ranged from 0.43 to 1.46 NTU in 
their low turbidity source. Similarly, Zhou (2016) provided a structure for categorizing TOC/DOC. 
Low TOC water was defined as generally less than 2 mg/L and medium TOC water was described 
as 2 to 5 mg/L, with >5 mg/L of DOC being described as high TOC. This is contradicted by 
Edzwald (1993) who describes a system with 30 NTU as low turbidity. All of these ranges are 
summarized in Table 2-3. 
Table 2-3. Publications Referencing Low Turbidity Source Water  
Publication  Definition of “low turbidity” 
(Edzwald, 1993) 30 NTU 
(Brink et al., 1988) ≤ 1 NTU 
(Al-Ani et al., 1986) < 1 NTU 
(Ongerth & Pecoraro, 1995) 0.5 to 5 NTU 
(Bustamante et al., 2006) < 3 NTU 
(Scott, 2008) 0.06 to 2.97 NTU (0.29 NTU, 
average) 




Regardless of the exact values that are used to define “high quality,” “low turbidity,” or “low 
TOC/DOC” source water, it is critical to note that the efficacy of CAF processes is typically solely 
indicated by achieving filter effluent turbidities below a specified value, typically <0.3 NTU or 
<0.1 NTU as discussed above in Section 2.3.1. However, when source water turbidity is already 
near this value and very little NOM is present to exert coagulant demand, it is possible that the 
achievement of low filter effluent turbidity may not be indicative of or attributable to adequate or 
optimal particle destabilization during chemical pre-treatment (i.e., coagulation). While the 
potential for such a scenario is speculative, it would explain why very low C. parvum oocyst 
reductions have been observed during the few available performance demonstrations in which 
oocysts were added to filter influent streams in which low turbidity, low DOC source water was 
being treated. Although the addition of oocyst seed suspensions effectively changed filter influent 
water quality, the seed suspensions were only coagulated at the full-scale plant coagulant dose that 
was optimized for the matrix prior to oocyst addition or not coagulated at all (Amburgey et al., 
2005; Emelko, 2001, 2003, Emelko et al., 2005, 2003; Huck, Coffey, Anderson, et al., 2002; Huck, 
Coffey, Emelko, et al., 2002; Scott, 2008).   
2.8 Key Knowledge Gaps  
While well-operated CAF remains a universally recognized, critical treatment process for 
removing protozoan pathogens from drinking water (Emelko et al., 2005; Ramsay et al., 2014); 
traditional filtered water monitoring strategies are ineffective at ensuring pathogen removal 
because: 
1. They do not broadly reflect operational capacity and resilience; 
2. Methods for the identification and enumeration of Cryptosporidium spp. and Giardia 
spp. are not available in real time and fraught with uncertainty, are expensive and 
extremely time consuming (Health Canada, 2012; Ryan & Hijjawi, 2015); and, 
3. No reliable surrogates for (oo)cyst removal by filtration exist (Headd & Bradford, 
2015; Payment, Plante, & Cejka, 2001; Tufenkji & Emelko, 2011).  
Critically, as discussed above, when CAF performance is sub-optimal, disease outbreaks (continue 
to) occur (Moreira & Bondelind, 2017), resulting in significant and often undocumented economic 
burden to society (Ridderstedt et al., 2017). Thus, a key knowledge gap in the water industry is 
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that tools that better support a CCP-based approach for ensuring protozoan pathogen removal by 
CAF are still needed.  
While monitoring of oocysts and cysts in CAF effluents is neither cost-effective nor possible in 
real-time, tools for signaling higher/lower risk periods for oocyst and/or cyst passage through CAF 
are likely available. Online turbidity and newly available online zeta potential analysis offer 
promise for real-time treatment and CAF performance optimization—the value of online zeta 
potential analysis was recently demonstrated during the 2013 Calgary flood (Kundert, Emelko, 
Mielke, Elford, & Ruecker, 2014) and the 2016 Horse River wildfire (Fort McMurray, AB) (Silins 
& Emelko, 2017). In combination with design and operational factors (e.g. backwash staggering), 
these tools offer a significant opportunity to address the knowledge gap identified above and 
develop improved CCP-based approaches for ensuring protozoan removal by CAF. This thesis 
research endeavors to contribute to addressing that goal.  
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Chapter 3 Materials and Methods 
3.1 General Research Approach 
Pilot-scale CAF experiments were conducted at the R.C. Harris Water Treatment Plant in the City 
of Toronto, Ontario, Canada. Phase 1 of this research involved the development and validation of 
a seeding protocol in which Cryptosporidium oocysts could be added to the influent stream pilot-
scale CAF processes to evaluate their removal in a manner reflecting optimal, “well operated” 
treatment of low turbidity, low DOC source water. To do this, a jar coagulation investigation was 
conducted to monitor turbidity and zeta potential during incremental additions of coagulant, 
aluminum sulfate (alum), to establish optimal particle destabilization and the coagulant dose 
required to achieve it. This test was followed by a series of pilot-scale CAF tests in which the 
dominant mechanisms of coagulation were investigated to validate the seeding protocol. To further 
validate the seeding protocol, a set of more environmentally relevant oocyst concentrations were 
seeded into the pilot filters over a longer duration using the Environmental Protection Agency 
(EPA) Method 1623.1 (USEPA, 2005).  
The development of this seeding protocol was critical to establishing the conditions under which 
pilot-scale CAF operation in an essentially direct filtration mode could be considered “well-
operated”. This protocol—and the capacity to identify appropriate particle (and oocyst) 
destabilization—was further critical given that oocysts were being added to a low turbidity, low 
DOC source water, thereby changing water quality substantially in most cases and potentially 
necessitating shifts in coagulant dosing for adequate particle destabilization.  Three sets of 
experiments were conducted during Phase 1. These were:  
1. Jar coagulation experiments were conducted to evaluate the extent of C. parvum oocyst 
destabilization achieved by coagulation to ensure that the developed experimental 
approach represented “well-operated” chemical pre-treatment of the low turbidity, low 
DOC source waters in which oocyst addition could change source water quality 
substantially; 
2. Pilot-scale CAF experiments were conducted to demonstrate that (1) sufficient 
chemical pre-treatment/coagulation of oocysts (or any other particles) is required to 
effectively neutralize/destabilize their surface charge during performance demonstrations 
22 
 
in order to reflect “well-operated” treatment (even when oocysts are added to clarified 
water) and (2) zeta potential analysis of coagulated filter influent/seed suspensions during 
a performance demonstrate can inform “well-operated” chemical pre-treatment prior to 
filtration; and,  
3. Seeding protocol validation experiments were conducted using lower/more 
environmentally relevant oocyst concentrations to confirm the validity of utilizing high 
oocyst concentrations in CAF performance demonstrations. 
The completion of Phase 1 was critical to enabling Phase 2, during which filter design and 
operational effects on C. parvum oocyst removal by CAF of low turbidity, low DOC source water 
were investigated to address another substantial knowledge gap. A variety of filter bed depths and 
operational conditions (e.g., hydraulic surges, ripening, end-of-run, increased hydraulic loading 
rate, and varied source water temperature) were evaluated. These experiments were conducted 
throughout the year to capture warm and cold water conditions. Based on the literature, the most 
vulnerable operational conditions, ripening (Logsdon, 2000; Nieminski & Ongerth, 1995), 
hydraulic surges and sub-optimal oocyst coagulation conditions were evaluated during cold water 
temperatures. For this system, cold water conditions were defined as settled water at or below 10 
°C as practiced by the City of Toronto. In addition to stable operating conditions (with optimal 
oocyst chemical pre-treatment during jar coagulation), hydraulic surges and sub-optimal oocyst 
coagulation conditions were evaluated. Zeta potential analysis was conducted during this phase of 
experimentation to evaluate the extent of chemical pre-treatment (i.e., optimal vs sub-optimal).  
3.2 Site Characteristics  
3.2.1 Source Water 
The experiments described herein were conducted at the City of Toronto’s pilot-scale CAF plant 
located in the Harris WTP. The Harris WTP has two intake pipes that draw Lake Ontario water 
from 2.3 km offshore at a depth of 15 m. All raw water was pre-chlorinated prior to conventional 
treatment of which a small fraction was diverted to the pilot plant. The pre-chlorinated water had 
a typical free chlorine residual of 0.50 mg/L and a total chlorine residual of 0.56 mg/L. A summary 
of the water characteristics during each experiment from the full- and pilot-scale plants is located 
in Appendix A and a summary of monthly raw water conditions can be found in Table 3-1. 
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Table 3-1. Nominal Raw Water Quality at the Harris Water Treatment Plant in Toronto 
between January 1, 2017 and April 24, 2018 (npH, turbidity = 470, nTOC = 16) 
 pH  Turbidity (NTU) TOC (mg/L) 
  Value 8.0 ± 0.15 0.24 ± 0.15* 2.0 ± 0.20 
                                          
*During a single event in April 2018 turbidity rose to 20 NTU 
Notably, the raw water turbidity during the experimental period averaged 0.24 NTU which is less 
than the 0.3 NTU effluent turbidity target set by Health Canada (2017) and the USEPA’s 
LT2ESWTR (2006b), and similar to the typical target of <0.1 NTU identified by the Partnership 
for Safe Water (AWWA et al., 2012) that is required by regulations like USEPA’s LT2ESWTR 
for an additional 0.5-log Cryptosporidium treatment credit (2006b). 
3.2.2 Harris Water Treatment Plant and Pilot Facility 
The pilot plant at the Harris WTP mimics the full-scale treatment plant configurations in Toronto’s 
four WTPs. The research described herein involved only the Harris WTP filter configuration which 
is the largest in Toronto with a treatment capacity of 950 million L/day. The process at this WTP 
consists of alum coagulation, flocculation, sedimentation, and dual media filtration. There are two 
treatment buildings: a pump house, and a multi-level building that houses treatment chemicals and 
40 anthracite/sand filters (300 mm of anthracite over 300 mm of sand, and 500 mm of support 
gravel). Typical operational parameters for the full- and pilot-scale Harris WTP are summarized 
in Table 3-2.  
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Table 3-2. Typical Range of Full- and Pilot- Scale Filter Operational Conditions in Toronto 
Parameter Full Scale Pilot Scale 
Alum dose (mg/L) 4 to 5 4 to 5 
Raw water turbidity (NTU) 0.28 0.28 
Raw water TOC (mg/L) 2.0 2.0 
Number of filters 40 2 
Filter surface area – total (m2)/filter 190 0.018 
Sand depth (mm) 250 to 300 250 to 300 
effective size (mm) 0.48 0.48 
uniformity co-efficient 1.4 1.4 
Anthracite depth (mm) 250 to 300 250 to 450 
effective size (mm) 0.95 0.95 
uniformity co-efficient 1.3 1.3 
Empty bed contact time (min) 13 to 16 13 
HLR (m/h) 2.0 to 9.0 2.0 to 5.0 
As can be seen in Table 3-2, the pilot plan was able to closely mirror the operational conditions of 
the full scale plant. The pilot plant is much smaller than the full scale plant; it is a two-story 
structure within one of the buildings of the Harris WTP. The flexibility of the set-up and smaller 
size of the pilot plant make it an ideal location to run tests on a variety of operating conditions or 
treatment configurations. In addition, the pilot allows for up to six filter column configurations on 
two separate trains (three columns on each train) to be run simultaneously. For the research 
described in this thesis, two filter columns were used on the same train, one to simulate the existing 
filters (referred to as shallow for this study) and one to investigate a proposed depth for new filters 
(referred to as deep for this study). For the purpose of this research, the focus was on the 
coagulation and filtration aspects of the treatment process, in Figure 3-1. 
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The CAF process investigated herein is reflected in the treatment from the settling basin to the 
waste stream in Figure 3-1. Settled water was used to create the seed suspension for each 
experiment. During the performance demonstrations inactivated C. parvum oocysts were added to 
settled water and coagulated with continuous mixing in beakers. Oocysts were added from a stock 
suspension of 109 oocysts in 1 mL of 5% formalin-inactivated oocysts without Tween 
(Waterborne, Inc., New Orleans, LA, USA) and were directly pipetted into the seed suspension. 
The volume of seed suspension created varied based on which experiment was conducted, and 
thus, the volume of oocyst added from the stock solution also varied by experiment. The aim for 
each seed suspension was a concentration of 107 oocysts/L; exact seed suspension volumes and 
enumerated oocysts concentrations in the seed suspension can be found in Appendix E. The seed 
suspension was pumped into the pilot filter influent stream, immediately before it enters the filter 
columns (Figure 3-2 and Figure 3-3).  
Chlorine Alum 











Figure 3-1. Process diagram of treatment stages from source water to pilot plant mimicking the 













Figure 3-2. Experimental design of the performance demonstrations to evaluate CAF of the 
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The seed suspension was added at this location (Figure 3-3, b) to allow for the oocysts to mix with 
the settled water stream in the pilot plant. Based on the small diameter and length of the piping 
used to add settled water to the filter column it was assumed that this allowed for proper mixing 
of the seed suspension into the settled water to occur prior to entering the filter column. Constant 
head was maintained in the filters during the experiments (3.7 m and 3.4 m from the base of each 
filter, shallow and deep, respectively).  
3.3 Phase 1 - Protocol Development for Conducting CAF Performance Demonstrations 
Three sets of preliminary experiments were conducted to develop and validate a protocol for 
creating a seed suspension to conduct performance demonstrations for oocyst removal by CAF of 




Figure 3-3. Ports used during Phase 1, Phase 2, and Seeding Protocol Validation 
Experiments performance demonstrations: a) piping where settled water mixed with 
oocyst seed suspension entered the filter column, b) port where seed suspension 
was introduced to the settled water stream prior to entering the filter column, and c) 
port where settled water was collected to create seed suspensions prior to the start 
of each experiment.  
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coagulation experiments, (2) pilot-scale CAF experiments, and (3) seeding protocol validation 
experiments. Together, these experiments investigated and validated strategies for achieving  
appropriate particle destabilization by coagulation prior to CAF of low turbidity, low DOC source 
waters and addressed the question of whether or not coagulation of oocysts prior to their addition 
to filter influent streams during CAF performance demonstrations is required. They are detailed 
below. 
3.3.1 Jar Coagulation 
These experiments were conducted to evaluate the extent of C. parvum oocyst destabilization 
achieved by jar coagulation prior to their introduction to filter influent streams. This was done to 
ensure that the experimental approach being utilized represented “well-operated” chemical pre-
treatment of low turbidity, low DOC source waters in which oocyst addition could change source 
water quality (e.g., turbidity) substantially. Zeta potential analysis was utilized to identify the 
minimum coagulant doses required to achieve adequate oocyst destabilization (i.e., “well-
operated” chemical pre-treatment)—this was expected to be a zeta potential of -7 mV, or a value 
less negative and closer to, but not exceeding the PZC (Pernitsky & Edzwald, 2006).  
A jar test apparatus (PB-700, Phipps and Bird, Richmond, VA, USA), turbidimeter (2100AN, 
Hach, Loveland, CO, USA), ZetaSizer Nano Z, and pH meter were utilized. Turbidity, zeta 
potential, and pH analysis protocols are also detailed below in Section 3.3.2, 3.3.3, 3.3.4, and 3.4.2. 
A single 2 L square jar was filled with settled water from the pilot plant. Measurements were taken: 
(1) prior to the addition of anything to the settled water, (2) following the addition of 107 oocysts/L 
to the settled water, and (3) following alum ((Al2(SO4)3•14(H2O), (ChemTrade Logistics, Toronto, 
Ontario, Canada) coagulant addition, which was added in 2.5 mg alum/L increments, until a final 
dose of 20 mg alum/L was achieved. The suspension was mixed at 80 RPM for one min after each 
alum addition followed by 15 min of settling time prior to taking any measurements.  
An additional test was conducted that used the same oocyst concentration and measured the same 
parameters to see if the results of incremental alum addition were similar to a single higher alum 
addition. A coagulant dose of 10 mg alum/L was selected. In this jar, measurements were taken 
prior to alum addition and once again after 10 mg alum/L was added instead of after 2.5, 5, 7.5, 
and 10 mg alum/L were added. 
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3.3.2 Pilot-scale CAF Performance Demonstrations 
These experiments were conducted to demonstrate the importance of adequate chemical pre-
treatment of oocysts (or any other particles) to optimize CAF performance and achieve maximal 
oocyst removal. Specifically, the ultimate goal of these experiments was to evaluate whether or 
not jar coagulation of oocysts during CAF performance demonstrations was necessary; and if so, 
to identify the appropriate coagulant dose that should be utilized during these demonstrations. In 
conducting these experiments, it was quickly observed that oocyst addition to the low turbidity, 
low DOC source water investigated frequently resulted in measureable and often substantial 
changes in turbidity. Therefore, it followed that the coagulant doses applied at the full-scale plant 
to destabilize particles in the source water might be insufficient for effective destabilization of the 
charged particles/oocysts in the same source water when oocysts were added at high concentrations 
(i.e., ~107 oocysts/L). In this case, insufficient chemical pre-treatment/coagulation would preclude 
optimal filtration performance/oocyst removal by CAF during the performance demonstrations. 
To investigate this possibility, a series of pilot-scale CAF filtration experiments was conducted.  
The pilot-scale CAF filtration experiments were conducted using two filter configurations 
representing those relevant to the full-scale Harris WTP. These included a relatively shallow filter 
bed consistent with the WTP’s full-scale configuration and a deeper bed configuration that could 
be implemented in the WTP. The pilot-scale filter operational conditions during these experiments 
are detailed in Table 3-3. 
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Table 3-3. Parameters for the Pilot Filters during Seed Suspension Protocol Development 
Parameter Value 
HLR 4.6 m/h 
Flow rate 1.4 L/min 
Shallow filter bed Anthracite 250 mm 
Sand 250 mm 
Gravel 500 mm 
Deep filter bed 
 
Anthracite 450 mm 
Sand 300 mm 
Gravel 500 mm 
The deep bed filter contained twice as much anthracite as the shallow bed filter (Figure 3-4). 
Before the beginning of each experiment the effluent sample lines (which were a side-stream off 
of the main filter effluent lines) were flushed and their flow rates were set to ~250 mL/min to 
ensure enough sample (~1 L) was collected during each 5 min interval of the 75 min long 
experiment. The effluent sample ports remained open (flowing) during the experiments. In 
contrast, the influent sample lines, remained closed between sample times to limit the loss of 




A series of five tests were completed during Phase 1, including two sets of back-to-back 
performance demonstrations. An approach similar to the seeding technique described by Emelko 
et al. (2003) was used. It included jar coagulation of formalin-inactivated oocysts in settled water 
prior to introducing the seed suspension into the filter influent stream where it was able to mix 
inline. Three alum doses (5, 22.5, and 40 mg alum/L) resulting in varying zeta potentials were 
utilized. Zeta potential was measured throughout the jar coagulation process (i.e., the zeta 
potentials of settled water, the seed suspension after oocyst addition, and the seed suspension after 
alum addition were evaluated). The filters were seeded with jar-coagulated oocysts suspended in 
Shallow Filter Deep Filter 
Figure 3-4. Shallow and deep bed filters in the Toronto R.C. 
Harris Water Treatment pilot plant used during Phase 1, Phase 
2, and seeding protocol validation experiments. 
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settled water for 60 minutes. Filter influent and effluent samples were collected every 15 min 
starting at time 0, for a total of 75 minutes in sterilized glass (Wheaton) bottles rinsed with eluting 
solution. Each filter effluent sample (~1 L) was collected over a 5-min period. Influent samples 
(~250 mL) were collected over a 0.5 min period. The filter influent and effluent sampling schedule 
during the Phase 1 pilot-scale CAF experiments is summarized in Table 3-4. Each operational 
condition is defined and discussed below (Sections 3.3.4 and 3.3.4.1). 
Table 3-4. Influent and Effluent Sampling Schedule during Phase 1 Pilot-scale CAF Experiments 
Experiment Type Sample Times from Start of Experiment (min) 
High HLR 0, 15, 30, 45, 60, 75, 90 
Ripening 0, 5, 10, 15, 20, 25, 30 
Middle/baseline 0, 15, 30, 45, 60, 75, 90, 105 
Low coagulant 0, 15, 30, 45, 60, 75, 90, 105 
End of run 0, 15, 30, 45, 60, 75, 90, 105 
Hydraulic surge 0, 50, 55, 61, 66, 71, 80, 100 
Visual indicators (i.e., pin floc formation) were utilized (to the extent possible) to differentiate 
between predominant coagulation mechanisms (i.e., sweep coagulation vs. adsorption and charge 
neutralization) in the seed suspensions (Amirtharajah & Mills, 1982). Notably, due to low 
concentrations of particles in low turbidity source waters, visual indicators could not be 
extensively relied upon to differentiate the balance between specific coagulation mechanisms 
(Brink et al., 1988), although some visualization of pin floc formation was possible with the correct 
lighting. Irrespective of the specific mechanisms that predominated in achieving optimal CAF 
performance, zeta potential analysis was used to identify key threshold doses associated with 
achieving optimal particle and oocyst destabilization in the seed suspensions. 
3.3.3 Seeding Protocol Validation Experiments   
A third set of experiments was completed using lower, more environmentally relevant oocyst 
concentrations to validate the use of high oocyst concentrations during pilot-scale CAF 
performance demonstrations. Two seeding protocol validation experiments were conducted. While 
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these experiments also involved pilot-scale CAF, they differed from the previous pilot-scale CAF 
experiments in several ways. Most importantly, the C. parvum oocyst concentrations in the filter 
influent streams in the seeding protocol validation experiments were lower/more environmentally 
relevant. Specifically, they were ~250 to 320 oocysts/L; approximately two orders of magnitude 
lower than those (~105 oocysts/L) used in the previous experiments. The use of high oocyst 
concentrations enabled easier, more rapid concentration and enumeration of oocysts by use of 
direct membrane filtration, IFA staining, and fluorescence microscopy as described in Emelko et 
al. (2003).  
In addition to the use of lower, more environmentally relevant filter influent oocyst concentrations, 
the entirety of the filter effluent was collected and filtered through EnviroChek® HV cartridges 
(Pall Gelman Laboratory, Ann Arbor, MI, USA) whereas in the previous experiments multiple, 
smaller volume samples were collected at prescribed time intervals. Finally, the HLR used during 
these experiments were consistent with those used in the full-scale WTP and lower than those used 
during the previous pilot-scale CAF experiments (2.3 vs. 4.6 m/h, respectively). Accordingly, a 
longer seeding and sample collection period (~11 times longer than in the previous pilot-scale CAF 
experiments) was required so that at least 3.0 log oocyst removal could be calculated. The main 
differences in CAF operations between the previous pilot-scale CAF and the seeding protocol 
validation experiments are summarized in Table 3-5. Similar results from the high and low filter 
influent oocyst concentrations indicated that the high oocyst concentration protocol developed was 
a valid method. 
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Table 3-5. CAF Operational Differences between Phase 1 Pilot-Scale CAF and Seeding Protocol 
Validation Experiments 
Parameter Pilot-scale CAF 
Seeding Protocol 
Validation 
HLR 4.6 m/h 2.3 m/h 
Flow rate 1.4 L/min 0.7 L/min 
Shallow filter bed anthracite 250 mm 250 mm 
sand 250 mm 250 mm 
gravel 500 mm 500 mm 
Deep filter bed anthracite 450 mm 
N/A sand 300 mm 
gravel 500 mm 
USEPA Method 1623.1 (2005) was used for oocyst identification and enumeration because it 
allowed processing of the large sample volumes required to complete these experiments. 
Specifically, four cartridges were used over an 8.5- and 10.5- h period respectively on consecutive 
days, which allowed for the experiments to be conducted at similar source water conditions. As 
per the method, ColorSeed™ (BTF, North Ryde BC, NSW, Australia) was used as an internal 
check standard for quantifying analytical recovery—the associated protocol is detailed in 
Appendix B. The samples were processed by the City of Calgary’s Canadian Association for 
Laboratory Accreditation (CALA) accredited laboratory where they were processed within the 96 
h time frame required by Method 1623.1 (USEPA, 2005). It should be noted that these experiments 
were only conducted using the shallow bed filter configuration. The two other filters in the filter 
train were turned off during these experiments so that all of the filter effluent entering the clearwell 




Figure 3-5. Filter effluent collection in Toronto R.C. Harris 
Water Treatment pilot plant clearwell during Seeding Protocol 
Validation Experiments. 
 
Figure 3-6. EnviroChek® HV cartridge and flow 
meter in Toronto R.C. Harris Water Treatment 




3.3.4 Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on C. 
parvum Oocyst Removal CAF of High Quality Source Water 
Phase 2 involved an evaluation of filter design and operational effects on C. parvum oocyst 
removal by CAF of low turbidity, low DOC source water. Summarized in Table 3-6, periods that 
have been previously identified as especially vulnerable to Cryptosporidium spp. oocyst passage 
through CAF processes including filter ripening (Emelko et al., 2005; Huck, Coffey, Emelko, et 
al., 2002), end-of run (Emelko, 2001; Emelko et al., 2005, 2003; Huck, Coffey, Emelko, et al., 
2002), and sub-optimal coagulation (Dugan et al., 2001; Emelko, 2001; Huck, Coffey, Anderson, 
et al., 2002; Huck, Coffey, Emelko, et al., 2002; Masher & Hendricks, 1986) were investigated. 
Hydraulic surges, which are understood to have highly variable effects on C. parvum oocyst 
passage through CAF processes (Emelko, 2001; Emelko et al., 2005, 2003; Huck, Coffey, Emelko, 
et al., 2002), were also evaluated. All these conditions were investigated during both cold and 
warm water temperatures entering the filters, with 10 °C marking the cut-off between warm and 
cold water temperatures. To easily distinguish between the experiments, each experiment was 
given a unique identifier, as listed in Table 3-7.  
Table 3-6. Samples Times and Oocyst Seeding Duration during Phase 2 Pilot-scale CAF 
Experiments conducted at the R.C. Harris Water Treatment Pilot Plant 
Experiment Type Sample Times from Start of Experiment (min) Seeding Duration (min) 
Ripening 0, 5, 10, 15, 20, 25, 30 0 to 30 
Middle/baseline 0, 15, 30, 45, 60, 75, 90, 105 0 to 95 
Sub-optimal coagulation 0, 15, 30, 45, 60, 75, 90, 105 0 to 95 
End of run 0, 15, 30, 45, 60, 75, 90, 105 0 to 95 
Hydraulic surge 0, 50, 55, 61, 66, 71, 80, 100 0 to 90; surge at 60 
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RIP-1 Warm 12.0 Ripening 40  
 
RIP-2 Cold 4.1 Ripening 40   
RIP-3 Cold 8.9 Ripening 40  Yes 
MID40-1 Cold  7.2 Middle 40  
 
MID40-2 Cold 9.7 Middle 40  
 
MID40-3 Cold 4.5 Middle 40  Yes 
MID40-4 Cold 4.6 Middle 40  Yes 
MID5-5 Cold 4.9 Middle 5  Yes 
MID0-6 Cold 5.0 Middle 0  Yes 
END Cold 8.9 End 40  Yes 
SUR-1 Warm 13.1 Hydraulic surge 40  
 
SUR-2 Warm 12.5 Hydraulic surge 40  
 
SUR-3 Cold 4.3 Hydraulic surge 40  
 
SUR-4 Cold 4.3 Hydraulic surge 40  
 
SUR-5 Cold 5.3 Hydraulic surge 40  
 
SUR-6 Cold 8.8 Hydraulic surge 40  Yes 
As illustrated in Table 3-7, settled water in the pilot plant ranged from and 4.1°C to 16.0°C during 
the Phase 1 and 2 experimental periods (both cold and warm water conditions). Notably and in 
contrast, the raw water temperature during the Phase 1 and 2 experimental period ranged from 2.2 
°C to 15.9 °C. Each experiment detailed in Table 3-7 was conducted concurrently using two filter 
bed depths in separate filters (Figure 3-4). The two filters were continuously fed from a single 
oocyst seed suspension. Unlike in Phase 1, the HLR in Phase 2 was set to match the full-scale plant 
(Table 3-8).  
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Table 3-8. Differences between Phase 1 and Phase 2 Pilot-scale CAF Experiments 
Parameter Phase 1 Phase 2 
HLR 4.6 m/h 2.3 m/h 
Flow rate 1.4 L/min 0.7 L/min 
Shallow filter bed anthracite 250 mm 250 mm 
sand 250 mm 250 mm 
gravel 500 mm 500 mm 
Deep filter bed anthracite 450 mm 450 mm 
sand 300 mm 300 mm 
gravel 500 mm 500 mm 
Based on the full-scale filter backwashing schedule, the pilot filters at the Harris WTP pilot were 
backwashed either 96 h after the previous backwash (more typical case) or after the accumulation 
of 3 m of head. Thus, in consultation with the pilot operator, the end-of-run experiments (END) 
were conducted as close to after 96 h of filter operation as possible. During the END experiment, 
the oocyst seed suspension was created as in Phase 1 and sample collection occurred at the same 
time points as the middle-of-run/stable operation experiments.  
During the hydraulic surge experiments, the pumps were shut down and started up as the filters 
were backwashed; this varied the loading rates in the filters that remained in service. A higher 
loading rate to the filters was investigated as increased loading may disrupt filter performance, 
potentially leading to particle detachment from filter beds. In these experiments, the HLR was 
increased from 2.3 m/h to 4.6 m/h over a 45 second interval at time 60 (min) when the filter was 
otherwise running optimally. To capture the surge event, two samples were collected prior to the 
surge (at time 50 and 55 min) to establish the filter’s baseline oocyst removal for that day. The 
surge was followed by 15 min of continuous effluent sampling (samples were collected every 5 
min) in an effort to capture any potential disruptions caused by the surge. The remaining samples 
were collected to describe the tail of the surge event. 
MID40-1 to MID40-4 sample ports were sampled using the same method as that used during the 
pilot-scale CAF experiments in Phase 1; the main difference between these experiments was the 
temperature because all of them were conducted under optimal coagulation (40 mg alum/L). In 
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addition to these experiments, two sub-optimal coagulation experiments were conducted at cold 
water temperatures: MID5-5 (5 mg alum/L) and MID0-6 (0 mg alum/L). These were conducted to 
evaluate filter performance at sub-optimal and no coagulant conditions to observe changes in zeta 
potential. They followed the same approach as the other middle of run experiments.  
3.3.4.1 Ripening 
Ripening experiments (designated RIP-1 through RIP-3) were also conducted during Phase 2. The 
initial improvement in filter effluent water quality, which typically occurred within the first 30 
minutes in the pilot-scale filters, occurs when a filter is put in service following backwash 
(ripening). The duration of the ripening period was approximately 60 minutes (until filter effluent 
turbidity reached a pseudo steady state), in both the shallow and deep filters. In order to capture 
the spike in turbidity, samples were collected in successive 5-minute intervals (Table 3-6). From 
the top of the filter column, where the oocysts were injected, oocysts travel time typically took 30 
minutes to reach a steady concentration at the surface of the filter media which was the entirety of 
the ripening spike. Therefore, to capture the ripening event and collect as many samples as 
possible, the tubing used to seed the oocysts into the filter column was lowered, closer to the top 
of the filter media. This allowed the oocysts to quickly reach the filter media in a timely manner 
so that samples could be collected to reflect filter performance during ripening. 
During ripening a longer set of tubing was needed to reach the top of the filter. Neoprene 
MasterFlex L/S 13 (ID: 0.8 mm) tubing was used to seed oocysts and neoprene MasterFlex L/S 14 
(ID: 1.6 mm) tubing was used for sample collection. Based on the design of the pilot filters, the 
only access point for additional tubing to reach the filter bed at the same height above both filters 
(shallow and deep) was from the top of the open filter. An additional challenge faced during the 
design of this experiment was a metal grate with 4 mm slats half way down each filter column 
which could not be removed. The tubing had to be moved through the grate in order to reach the 
top of the filter bed. To compensate for the flexibility of the tubing, a small rod was taped (to cover 





Figure 3-7. The deep bed filter in Toronto R.C. Harris Water Treatment pilot plant during 
ripening experiment. Tubing with a small rod attached to: fit through metal grate half way down 
the filter column, and be closer to the filter bed to shorten the oocyst travel time and capture the 
30 minute ripening period. 
Initially, the influent sampling tubing was positioned to collect samples 76 mm above each filter 
media surface and the oocyst seeding tubing discharged 305 mm above the filter bed. This was 
done to have the oocysts reach the filter bed as quickly as possible from the influent tubing. 
However, after comparing the influent concentrations from the first two ripening experiments with 
the other experiments that had been conducted, it was determined that there was insufficient time 
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and/or distance for the oocysts to properly mix with the water above the media. A third experiment 
was conducted with the influent sampling tube repositioned 127 mm above the filter media surface. 
The rationale for this was to allow for adequate mixing to occur above the filter.  
To ensure that the lower influent oocyst concentration was not due to losses in the longer seeding 
tubing, recovery tests were conducted and it was found that no significant losses were attributable 
to the tubing (Appendix C).  
3.4 C. parvum Oocyst Analyses 
3.4.1 Concentration, Purification, and Enumeration Techniques 
With the exception of oocyst samples collected during the Seeding Protocol Validation 
Experiments, all C. parvum oocyst concentration, purification, and enumeration analyses in Phases 
1 and 2 were conducted following the direct membrane filtration, IFA staining (Crypt-a-Glo, 
Waterborne Inc., New Orleans, Louisiana, USA), and fluorescence microscopy at 200x 
magnification (Axioskop 2 plus, Zeiss, Göttingen, Germany) technique described by Emelko et al. 
(2003). In brief, ~700 mL (on average) of filter effluent and 1 mL of filter influent were measured 
and filtered through 0.4 μm nominal porosity polycarbonate filter membranes (Whatman 
Nuclepore®, Whatman Inc., GE Healthcare Life Sciences, Mississauga, ON, CA) placed on top 
of 8.0 μm nominal porosity cellulose acetate support membranes (Whatman Nuclepore®, 
Whatman Inc., GE Healthcare Life Sciences, Mississauga, ON, CA) on a manifold or in a syringe 
filter. Filter influent samples were processed using 13 mm diameter membranes and 25 mm 
diameter membranes were used for filter effluent samples. Crypt-a-Glo IFA stain was then applied 
to the filter membrane surfaces and the manifolds were incubated at 35 °C for a minimum of 25 
min, as per supplier instructions. The membranes were then mounted on glass slides for oocyst 
enumeration. Counts of 30 to 100 oocysts per slide were targeted (Emelko et al. 2008). The 
membrane filtration characteristics and IFA stain volume used to process oocyst samples collected 
during Phase 1 and 2 pilot-scale CAF Experiments are summarized in Table 3-9. 
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Table 3-9. Crypt-a-Glo Volume and Membrane Filter Characteristics used to process Oocyst 
Samples Collected during Pilot Plant Experiments 











Diameter 13 mm 13 mm 25 mm 25 mm 
Pore Size 0.4 μm 0.4 μm 0.4 μm 0.4 μm 
Type polycarbonate  polycarbonate  polycarbonate  polycarbonate  
Support 
Membrane 
Diameter 25 mm 13 mm 25 mm N/A 
Pore Size 8.0 μm 8.0 μm 8.0 μm N/A 
Type cellulose cellulose cellulose N/A 
Vol. of Crypt-a-Glo 100 μL 50 μL 200 μL 200 μL 
N/A – not applicable, the glass manifold did not require the use of the support membranes 
The same process utilized for the influent samples was utilized to enumerate the oocyst 
concentration of the seed suspensions used during each experiment. Based on the higher 
concentration of oocysts in the seed suspensions from each experiment, the volume filtered 
through the syringes was modified to 10 μL. 
3.4.1.1 Quantifying Oocyst Removal 
To assess removal of C. parvum oocysts by filtration, the log reduction between the influent and 
effluent samples was calculated. In order to accurately describe the removal achieved during each 
experiment (run), the average oocyst removal was calculated based on the averaged, normalized 
influent and effluent concentrations.  
 




When calculating the oocyst removal for individual time intervals of each run (for box and whisker 








The main difference was that the effluent concentration was specific to the time interval instead of 
an overall experimental average. Table 3-10 summarizes the samples that were used to calculate 
the average oocyst removal for each type of experiment. When calculating averages, influent slide 
concentrations (typically n=5) from the below mentioned periods were averaged before calculating 
the log removal. This was done because log10 values should not be averaged. Notably, the seed 
suspension was injected into the settled water influent line that discharges into the top of the filter, 
about 3 to 4 m above the actual water/media interface. Thus, oocyst travel time in the column 
needed to be accounted for when calculating the average oocyst removal for each experiment.  
Table 3-10. Calculation of Oocyst Removal Averages 
Experiment 
Sample Times from Start of 
Oocyst Addition (min) 
Period in 
Average 
Middle 0, 15, 30, 45, 60, 75, 90, 105 45 to end 
End 0, 15, 30, 45, 60, 75, 90, 105 45 to end 
Ripening 0, 5, 10, 15, 20, 25, 30 10 to end 
Surge 0, 50, 55, 61, 66, 71, 80, 100 61 to end 
In addition to the information in Table 3-10, the influent values used to calculate oocyst removal 
were also adjusted. Ultimately, each type of experiment used a single influent value to calculate 
the oocyst removals for both individual time intervals and experimental averages. This was done 
because each experiment had the same seed suspension concentration and was enumerated using 
the same technique. This allowed for more consistent comparison between experiments of the 
same type, between the two filters, and between the various time intervals within sample. By doing 
this some of the variability between samples within an experiment and between experiments was 
removed.  
When a zero count was encountered, a value of 1 was put in place of it to provide a conservative 
estimate of the removal achieved. This affected the shape of some box and whisker plots which 
44 
 
resulted in no error/variance bars. Because influent oocyst concentrations were averaged for each 
run (Equation 3), the removal values were often identical for multiple time intervals. Based on 
how box and whisker plots are created (i.e. differences between quartile values and 
maximum/minimum values) in combination with averaging influent concentrations, this 
sometimes resulted in no boxes on the plots.  
3.4.2 Zeta Potential Analysis 
Zeta potential was evaluated (whenever possible) using a ZetaSizer Nano Z. Samples were 
collected prior to oocyst addition to the settled water (SW), after oocyst addition to settled water 
(SW + O), and after alum addition to the seed suspension (SW + O + alum). Between each reading, 
the syringe used to collect the samples, and the cartridge used by the ZetaSizer Nano Z were rinsed 
with settled water from the pilot plant. Each sample value was the average of three individual 
readings, which were taken consecutively and 10 seconds apart (averaged manually).  
3.4.3 Statistical Analysis of Data 
Prior to conducting any quantitative comparisons of oocyst removal with different filter 
configurations or operational conditions, the data were grouped (Table 3-7) and normality was 
evaluated using a combination of the Shapiro-Wilks test, histograms, and Q-Q plots (Appendix D) 
using RStudio open source software (RStudio, Boston, MA, USA). The grouped data were further 
divided into shallow and deep bed configurations. The distributions of oocyst removals achieved 
by CAF were not always consistent with the normal distribution—this was especially expected 
during dynamic periods in the filter cycle, including ripening and hydraulic surges. Thus, the non-
parametric Mann-Whitney U-test was utilized to evaluate whether or not the sample means from 
the data sets came from the same or different distributions. The p-value outputs from the Mann-
Whitney U-test were compared and assessed at the 5% significance level. Oocysts removal by 
CAF was quantitatively compared between (1) stable and various CAF operational conditions; 
(2) cold and warm settled water temperatures; and (3) shallow versus deep filter bed 
configurations, as summarized in Table 3-11.  
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Table 3-11. Quantitative Comparisons of C. parvum Oocyst Removal Performance by CAF 
during Phase 2 Pilot-scale CAF Experiments 
Condition Evaluated Base Data Set Comparison Data Set 





SUR-1 to SUR-5 
SUR-6 
SUR-1 to SUR-6 
Settled Water Temperature (warm) 
MID40-1 
SUR-2 & SUR-3 
(cold) 
MID40-2 to MID40-4  
SUR-1, SUR-4 & SUR-5  
Filter Bed Depth (shallow) 
RIP-1 to RIP-3 
MID40-1 to MID40-4 
MID5-5 & MID0-6 
END-1 
SUR-1 to SUR-6 
(deep) 
RIP-1 to RIP-3 
MID40-1 to MID40-4 
MID5-5 & MID0-6 
END-1 
SUR-1 to SUR-6 
*compared with every other condition in Comparison Data Set column  
The p-value outputs from the Mann-Whitney U-test were compared to test the null hypothesis. If 
the outputs were less than 0.05 the two sets of data were considered non-identical.  
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3.5 Lab Equipment Procedures 
Between experiments all lab equipment (i.e. not pilot plant equipment) and all sampling bottles 
were cleaned which were rinsed with acetone, rinsed with deionized water, and autoclaved 
between uses. Multiple syringe tips and manifold components were rinsed with acetone in a beaker 
which was filled with deionized water after the initial rinse. After at least 30 minutes had passed, 
all equipment was rinsed with deionized water and autoclaved for the next sample. Graduated 
cylinders were cleaned in a similar fashion. Acetone was pipetted into the cylinder, careful to cover 
the entire interior circumference of the cylinder, and filled with deionized water. Again, after at 
least 30 minutes they were rinsed 3 times with deionized water and autoclaved for the next sample. 
Lastly, syringe tips, manifold components, and cylinders were placed in the autoclave. 
Prior to removing waste from the sample bottles, the bottles containing the remaining samples 
were autoclaved on liquid cycle followed by the addition of 3 mL of acetone and were left 
overnight. The resulting waste was removed from the bottles which were then dish washed and 
dried. The waste water containing acetone was disposed of using the chemical disposal in the 
Douglas Wright Engineering building on the University of Waterloo campus. Clean equipment 
was kept in a common area but labelled for this research. Any items that may have been used by 
others or mislabelled during cleaning were re-cleaned to ensure the proper steps were taken to 
avoid cross-contamination.  
Prior to each experiment in the Toronto WTP, clean bottles were rinsed with eluting solution, 
autoclaved, and labelled. The eluting solution was added to all sampling bottles as a means to limit 
the number of oocyst that could remain attached to the bottle during filtration and IFA processes. 
The only bottle not rinsed with eluting solution was the bottle used to create the seed suspension 
during each experiment to eliminate the number of external factors that would interfere with zeta 
potential measurements.   
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Chapter 4 Results and Discussion 
4.1 Phase 1 Results 
Phase 1 involved the design and investigation of a seeding protocol for optimized oocyst removal 
by CAF of high quality source water. Three sets of experiments were conducted: (1) jar coagulation 
experiments, (2) pilot-scale CAF experiments, and (3) seeding protocol validation experiments. 
These results from these experiments are discussed in detail below.  
4.1.1 Seed Suspension Protocol Development 
These experiments were conducted to evaluate the extent of C. parvum oocyst destabilization 
achieved by coagulation, to ensure that the developed experimental approach represented “well-
operated” chemical pre-treatment of the low turbidity, low DOC source waters in which oocyst 
addition could change source water quality substantially. C. parvum oocysts were added to 2 L of 
settled water to achieve a target concentration of 107 oocysts/L. Alum was added in 2.5 mg/L 
increments and turbidity, pH and zeta potential were analyzed to identify the minimum coagulant 
dose required to achieve oocyst destabilization (i.e., “well-operated” chemical pre-treatment). As 
discussed in Sections 2.5 and 3.4.2, this was expected to be a zeta potential of -7 mV or a value 
less negative, and closer to, but not exceeding the PZC. The turbidity, pH, and zeta potential data 
collected during the Phase 1 jar coagulation experiment are presented in Table 4-1.   
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Table 4-1. Oocyst Seed Suspension Characteristics resulting from Increased Coagulant Addition 














-- 0.0 0.22 7.7 -18.1 
oocysts 0.0 0.70 7.8 -19.7 
alum 2.5 0.35 7.5 -15.8 
alum 5.0 0.39 7.5 -16.5 
alum 7.5 0.52 7.3 -13.7 
alum 10.0 0.62 7.2 -14.8 
alum 12.5 0.73 7.1 -9.7 
alum 15.0 0.79 6.9 -4.5 
alum 17.5 0.90 6.9 -2.5 
alum 20.0 0.79 6.9 -2.3 
* following a 15 min settling time 
As would be expected for such a low turbidity source water, oocyst addition substantially increased 
the seed suspension turbidity from 0.22 to 0.70 NTU. Thereafter, turbidity in the seed suspension 
increased (up to a point) with increasing alum coagulant addition (Figure 4-1). The initial increase 
in turbidity was due to the lack of particulate matter initially present in the water matrix. As alum 
was added to the oocyst seed suspension, the coagulation regime and associated predominant 
coagulation/particle destabilization mechanisms shifted from a combination of adsorption and 
charge neutralization, and sweep coagulation (i.e., precipitation of aluminum hydroxide solid 
[Al(OH)3 (s)] coupled with increased contact opportunities for flocculation resulting from the 
formation of that solid) to increasingly more sweep coagulation, as described by Amirtharajah & 
Mills (1982). In the present experiments, as sweep coagulation ultimately became the predominant 
coagulation mechanism, small, pin flocs formed and were eventually visible. Concurrently, some 
turbidity reduction during settling was observed. Here, this behavior was observed at alum doses 
of 15 to 20 mg/L (Figure 4-1).  
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Figure 4-1. Results from Phase 1 jar coagulation investigation 
The pH of the seed suspension decreased with increasing alum addition, as would be expected as 
result of the addition of an acidic coagulant to a water matrix with relatively low alkalinity; 
notably, the zeta potential became less negative with increased alum addition (Figure 4-1). It was 
-18.1 mV initially and decreased to -19.7 mV after the addition of the negatively charged oocysts. 
The seed suspension zeta potential at the full-scale WTP’s applied alum dose of 5 mg/L was -16.5 
mV. Based on the general suggestion of Pernitsky (2003) and the broader understanding the filter 
influent zeta potential should be in the vicinity of the PZC, ± 4mV of 0 mV, (but still negative so 
as not to unnecessarily over-coagulate) to achieve optimal particle and oocyst (Bean et al., 1964; 
Bustamante et al., 2006; Cleasby et al., 1963; Ghernaout, 2015; Gupta et al., 1973; Karaman et al., 
1999; Neuman, 1981; Riddick, 1961; Xagoraraki & Harrington, 2004; Xu, Fitzpatrick, & Deng, 
2006) removal by CAF. Using the PZC, these data indicate that full scale plant alum dose of 5 
mg/L likely would be insufficient for achieving optimal CAF treatment performance; rather, doses 
of 15 mg/L or more would be expected to be more likely to result in optimal particle and oocyst 
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It should be noted that a settling period was used during these experiments to observe the effect of 
settling during the relatively short (15-minute) settling period; and if so, to identify the associated 
alum dose. It should be further underscored that the seed suspensions were continuously stirred as 
they were added to filter influents during subsequent pilot-scale CAF experiments. During those 
experiments, alum doses (such as the ~15 mg/L dose observed here) resulted in the formation of 
small pin flocs that were barely visible. Coagulation resulting in pin floc formation is appropriate 
for achieving optimal particle removal by direct filtration (Crittenden et al., 2012), which is 
effectively what was conducted in the subsequent phases of this work (Sections 4.1.2 and 4.2) 
because the oocysts seed suspensions were being added directly to filter influent streams. 
An additional experiment was conducted to demonstrate that at the process of incremental alum 
addition during the jar coagulation experiments described in Section 3.3.1 and presented above 
(Table 4-1), resulted in comparable turbidity, pH and zeta potential.  During this experiment, a 10 
mg/L was added directly to the water matrix containing the C. parvum oocysts. This resulted in a 
zeta potential of -14.4 mV and turbidity of 0.963 NTU (-14.8 mV and 0.623 NTU during the 
incremental coagulant additions). Importantly, these data demonstrate the post-coagulation water 
quality was not meaningfully impacted by the incremental addition of alum that was required to 
identify the level of alum addition that was expected to result in optimal particle and oocyst 
removal by CAF (i.e., “well-operated” treatment) of any given filter influent matrix. This 
expectation was confirmed during the Phase 1 pilot-scale CAF Experiments described in the next 
section below (Section 4.1.2). 
4.1.2 Pilot-scale CAF Experiments 
Pilot-scale CAF experiments were conducted to demonstrate that (1) sufficient chemical pre-
treatment/coagulation of oocysts (or any other particles) was required to effectively 
neutralize/destabilize their surface charge during performance demonstrations in order to reflect 
“well-operated” treatment (even when oocysts are added to clarified water) and (2) zeta potential 
analysis of coagulated filter influent/seed suspensions during performance demonstrations can 
inform “well-operated” chemical pre-treatment prior to filtration. Specifically, five pilot-scale 
CAF experiments were conducted. In brief, filtration using shallow and deep bed anthracite/sand 
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filter configurations was investigated. The experimental CAF design and operation details were 
presented in Section 3.3.2 and Table 3-2.  
Following up on the analysis presented in Section 4.1.1, jar coagulation of the oocyst seed 
suspensions introduced into the filter influent streams was investigated using three alum doses: 
(1) 5 mg alum/L to mimic the alum dose typically applied at the full-scale Harris WTP, 
(2) ~22.5 alum mg/L to yield zeta potentials less negative than ~-7 mV and somewhat visible pin 
floc formation, and (3) 40 mg alum/L to yield negative zeta potentials closer to the PZC than those 
achieved with the 22.5 mg/L alum dose and clearly visible pin floc formation. After one initial 
experiment, back-to-back sample dates were chosen for subsequent experiments to ensure that 
environmental conditions, especially source water quality and temperature, were as consistent as 
possible so that optimal alum dose concentrations would not vary substantially between the 
experiments. An initial experiment using 22.5 mg alum/L was conducted on May 11, 2017. The 
back-to-back experiments were conducted in the following pairings: 22.5 mg alum/L and 40 mg 
alum /L (on June 8 and 9, 2017), and 5 mg alum /L and 40 mg alum/L (on August 2 and 3, 2017). 
The repetition of the experiment with the addition of 40 mg/L of alum to the seed suspension 
served as a common point of comparison between the sets of experiments.  
C. parvum oocyst removal by shallow and deep bed filters during the Phase 1 pilot-scale CAF 
experiments is summarized in a box-and-whisker plot (Figure 4-2) and Table 4-2. In these plots, 
the line in the center of the box represents the median (50th percentile) oocyst removal by the CAF 
process. The lower and upper portions of the box respectively indicate the 25th and 75th percentile 
oocyst removals achieved by the CAF process. The lower and upper portions of the line (whisker), 
respectively, represent the minimum and maximum oocyst removals achieved by the CAF process  
In this and all ensuing figures, the 3.0-log oocyst removal that is expected from “well-operated” 
CAF in most North American drinking water regulatory policies (Health Canada, 2012; USEPA, 




  May 11/17          Jun. 8/17  Jun. 9/17    Aug. 2/17          Aug. 3/17 
   22.5 mg/L               22.5 mg/L  40 mg/L      5 mg/L            40 mg/L 
Shallow Bed       Deep Bed 
Figure 4-2. Box and whisker plot comparing C. parvum oocyst removal in shallow and deep bed 
filters during Phase 1 Pilot-scale CAF experiments. 
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Table 4-2. Phase 1 Pilot-scale Experiment Summaries 
Exp. ID Alum Dose (date) 





Shallow Bed Deep Bed 
P1 – 22.5a 22.5 mg alum/L (May 
11th) 
2.0 1.5 N/A 
P1 – 22.5b 22.5 mg alum/L (Jun. 8th) 3.5 3.8 -9.5 
P1 – 40a 40 mg alum/L (Jun. 9th) 4.1 3.3 -5.2 
P1 – 40b 40 mg alum/L (Aug. 3rd) 3.6 3.8 -7.1 
P1 – 5 5 mg alum/L (Aug. 2nd) 1.2 1.2 -15.5 
The data in Figure 4-2 generally suggest two operational scenarios: (1) >3-log removal of 
C. parvum oocysts when there was sufficient oocyst destabilization by coagulation that enabled 
optimized oocyst removal by CAF and (2) <3 log removal of C. parvum oocysts when there was 
insufficient oocyst destabilization by coagulation and associated sub-optimal oocyst removal by 
CAF.  Notably, although zeta potential data were not available for the initial experiment conducted 
on May 11th, 2017, it is likely that oocyst destabilization was insufficient on this occasion—oocyst 
removal by CAF likely would have been better if a higher alum dose had been utilized. This 
hypothesis is generally supported by the other data collected later in this study, in which good 
oocyst removals (i.e., >3-log) by CAF were observed in both the shallow and deep bed filters when 
seed suspension zeta potentials were generally smaller in magnitude than -10 mV (i.e. between -
5.2 and -9.5 mV), while more negative seed suspension zeta potentials (at least -15.6 mV) resulted 
in lower (<3-log) oocyst removals by CAF (Table 4-2). Notably, although the deep and shallow 
bed filters generally performed similarly; with the exception of the initial experiment, oocyst 
removal by the deep bed filter was less variable and frequently better than the achieved by the 
shallow bed filter (Figure 4-2 and Table 4-2). Mean oocyst removals that were achieved by these 
different filter configurations were generally similar for a given operational condition, however; 
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thereby underscoring the critical importance of sufficient chemical pre-treatment/coagulation for 
effective and optimal particle and potential pathogen removal by CAF processes. 
4.1.3 Seeding Protocol Validation Experiments  
To confirm the validity of utilizing high oocyst concentrations in CAF performance 
demonstrations, two experiments were conducted using lower (by two orders of magnitude)/more 
environmentally relevant oocyst concentrations so that these results could be compared to those 
obtained from performance demonstrations conducted at the same operational conditions, but with 
higher oocyst concentrations. Thus, these experiments were designed to validate the use of alum 
doses that were higher than those used by the full-scale WTP when coagulating oocyst seed 
suspensions in order to ensure that sufficient particle/oocyst destabilization occurred and well 
operated CAF was evaluated. The operational conditions and experimental data associated with 
these experiments are provided in Table 4-3.  
Table 4-3. Overview of Operational Conditions and Experimental Data from the Phase 1 Seeding 
Protocol Validation Experiments  






















July 16, 2018 20 - 8.0 1  5.6E+04 231 3 4.7 
2  4.4E+04 180 29 3.6 
July 17, 2018 7.5 -11.1 1  3.9E+04 140 41 3.4 
2  6.4E+04 185 2 4.9 
* C. parvum oocysts recovered from cartridges fed with filter effluent 
In contrast to the pilot-scale CAF experiments in which matched filter influent and effluent pairs 
of data were used to calculate oocyst removals, the entire filter effluent flow was filtered in the 
present experiments. The total number of oocysts captured in each of two cartridges was compared 
to the number of oocysts introduced in the filter influent to calculate oocyst removal by CAF which 
are presented in Table 4-3.  
55 
 
Critically, it must be emphasized that the alum doses used during these experiments were lower 
than those used in the previous pilot-scale CAF experiments. The alum doses were selected to 
achieve seed suspension zeta potentials in the approximate vicinity of -7 mV (July 16) and 
equivalent to those used by the full-scale WTP (July 17). As in the previously reported pilot-scale 
CAF experiments, alum was added in 2.5 mg/L increments, as shown in Figure 4-3. These 
experiments demonstrated that similar, excellent (i.e., >3-log) C. parvum oocyst removals by CAF 
were achieved, irrespective of alum dose and filter influent oocyst concentration as long as 
sufficient oocyst destabilization was achieved in the seed suspension (as evidenced by zeta 
potential) prior to introducing the seed suspension to the filter influent stream.  
  





























Interestingly, it is possible that the change in predominant coagulation regime (i.e., shifting from 
adsorption and charge neutralization to sweep coagulation) as described by (Edzwald & Lawler, 
1983) was observed during the July 16 experiment. The less negative zeta potential observed at an 
alum dose of 7.5 mg/L may have corresponded to the optimal observed particle/oocyst 
destabilization by adsorption and charge neutralization and subsequent, more negative zeta 
potentials that were observed as alum dose further increased could indicate charge reversal. 
Subsequent improvement in zeta potentials (to less negative values) with additional alum addition 
would then have been associated with the emergence of sweep coagulation as the predominant 
particle/oocyst destabilization mechanism. This effect was not investigated during the second 
experiment (on July 17) because that experiment was exclusively focused on mirroring the full-
scale alum dose in the seed suspension; nonetheless, a similar trend in zeta potential did begin to 
emerge.  
4.2 Phase 2 Results 
Upon completion of Phase 1, filter design and operational effects on C. parvum oocyst removal by 
CAF of low turbidity, low DOC source water were investigated. All of the experiments conducted 
during Phase 2 used the same set up as in Phase 1, which included using settled water as the base 
for the seed suspension. One major difference between the pilot experiments using this protocol in 
Phase 1 and Phase 2 was the hydraulic loading rate which was reduced to 2.3 m/h (from 4.6 m/h) 
to mirror that of the Harris full-scale WTP. Based on the range of results observed during Phase 
1, a set alum dose of 40 mg/L was used during Phase 2 to ensure optimal particle/oocyst 
destabilization and pin floc formation (i.e., well-operated CAF with optimal particle/oocyst 
destabilization) without needing to go through the somewhat labor-intensive process of 
incremental coagulant addition and manual evaluation of seed suspension zeta potential.   
4.2.1 Filter Operational Conditions 
A total of 16 experiments were conducted to investigate C. parvum oocyst removal by CAF of low 
turbidity, low DOC water by shallow and deep dual media filters, at warm and cold water 
temperatures, during hydraulic surges, periods of filter ripening, end-of-run filter operation, and 
sub-optimal coagulation. These are summarized in (Table 3-7).  
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4.2.1.1 Stable Filter Operation and Sub-optimal Coagulation during Middle of Run  
Four sets of stable filter operation experiments and two sets of sub-optimal coagulation 
experiments were conducted during the middle portion of the filter cycle. The details of the 
experiments are summarized in Table 4-4 and Figure 4-4.  Detailed results from these experiments 
can be found in Appendix E. Importantly, quantification of C. parvum oocyst removal by CAF 
during stable filter operation established a baseline for process performance during warm and cold 
water conditions and also provided a basis for comparison when other operational conditions were 
investigated.  
Table 4-4. Oocyst Removals from Phase 2 Middle of Run Experiments during Stable Filter 










Avg. Oocyst Removal 
(log10) 
Shallow Bed Deep Bed 
MID40-1 7.2 40 N/A 3.8 3.9 
MID40-2 9.7 40 N/A 4.3 4.9 
MID40-3 4.5 40 0.1 5.4 5.4 
MID40-4 4.6 40 2.0 4.7 4.2 
MID5-5 4.9 5 -10.0 2.4 1.9 











During stable filter operation, C. parvum oocyst removal by shallow and deep bed CAF ranged 
from 3.8 to 5.4 log (Table 4-4 and Figure 4-4). As would be expected, C. parvum oocyst removals 
by deep and shallow bed CAF during sub-optimal coagulation conditions were significantly 
different from those observed during stable filter operation (5% significance level). These results 
align well with the Phase 1 results (discussed in Section 4.1.2) and highlight the importance of 
achieving sufficient particle/oocyst destabilization by coagulation to reflect well-operated CAF. 
Thus, they also underscore the importance of ensuring sufficient jar coagulation of oocyst seed 
suspensions during CAF performance demonstrations, especially during treatment of low 
turbidity, low DOC source waters for which filter effluent turbidity alone may not be adequately 
indicative of sufficiently destabilized particles/oocysts, and therefore, well-operated treatment. 
The results from these experiments also are generally consistent with previously reported 
Figure 4-4. C. parvum oocyst removal by CAF during Phase 2 middle-of-run, 40 mg alum/L 
(MID40-1 to MID40-4) and sub-optimal coagulation (MID5-5, MID0-6), 5 and 0 mg alum/L, 
experiments 
Shallow Bed       Deep Bed 
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C. parvum oocyst removal by CAF data from other systems (Barkay-Arbel et al., 2012; Brown & 
Emelko, 2009; Dai & Hozalski, 2002; Edzwald & Kelley, 1998; Emelko, 2003; Huck et al., 2002; 
Keegan et al., 2008; Logsdon, 2000; Nieminski & Ongerth, 1995; Ongerth & Pecoraro, 1995; 
Shaw et al., 2000; Torabian et al., 2008). Notably, they are consistent with the high levels (overall 
5.5 log) of oocyst removal during stable operation by CAF of moderate turbidity, moderate DOC 
source water, that were previously reported for a system in Ottawa, Canada (Emelko, 2001; Huck 
et al., 2002). CAF during sub-optimal coagulation conditions (MID5-5 and MID0-6) resulted in 
median C. parvum oocyst removals of less than 3-log. This result also is consistent with previous 
research (Dugan et al., 2001; Emelko, 2001; Huck, Coffey, Anderson, et al., 2002; Huck, Coffey, 
Emelko, et al., 2002; Masher & Hendricks, 1986) that demonstrated that oocyst passage through 
CAF processes can substantially increase during sub-optimal coagulation conditions, especially 
when coagulant residual (i.e., metal hydroxide precipitate) is not present in treatment units 
preceding filtration (Emelko, 2001; Huck et al., 2002; Emelko et al., 2003). Table 4-5 provides 
statistical evidence that, when compared to the experiments conducted under stable filter 
operation, MID5-5 and MID0-6. 
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Table 4-5. Comparison of Oocyst Removals during Stable Operation to those during Sub-
Optimal Coagulation (MID5-5 and MID0-6) using the Mann-Whitney U-test  
Experiment  p-value* W 
MID5-5 Shallow Bed 0.00061 115 
Deep Bed 0.00094 113 
MID0-6 
 
Shallow Bed 0.00061 115 
Deep Bed 0.00061 115 
*when p-value < 0.05, reject null hypothesis: samples come from the same distribution, no difference in 
medians 
 
The p-value is lower than 0.05 for both experiments at both filter bed depths which indicates that 
there is a difference between stable filter operation experiments and the two sub-optimal filter 
experiments. 
4.2.1.2 Ripening 
Three sets of ripening experiments were conducted and are summarized in Table 4-6 and Figure 
4-5. Full results from ripening and all other Phase 2 experiments, can be found in Appendix E. 










Avg. Oocyst Removal 
(log10) 
Shallow Bed Deep Bed 
RIP-1 12.0 40 N/A 2.8 2.7 
RIP-2 4.1 40 N/A 2.1 2.6 
RIP-3 8.9 40 1.3 3.0 3.3 






C. parvum oocyst removal by CAF of low turbidity, low DOC source water did not always exceed 
the 3-log removal target during filter ripening. It is important to note that the experimental 
configuration was altered for the RIP-3 experiment, as discussed in Section 3.3.4.1. Briefly, the 
tube that introduced the oocyst seed suspension to the filter influent was moved to a location 17.8 
cm higher above the filter bed, which allowed for additional mixing of the seed suspension in the 
filter influent stream prior to the collection of filter influent samples. After implementation of this 
change, median C. parvum oocyst removals by CAF during filter ripening were >3.0-log. These 
results underscore the importance of experimental design during CAF performance 
demonstrations. 
Shallow Bed       Deep Bed 
Figure 4-5. C. parvum oocyst removal during Phase 2 filter ripening experiments 
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The significance of the ripening test results was evaluated both jointly and with RIP-3 in isolation 
(Table 4-7). In all cases, C. parvum oocyst removal by deep and shallow bed CAF during filter 
ripening was significantly different than that measured during stable filter operation (5% 
significance level). The results observed herein are consistent with other reports of C. parvum 
oocyst removal by CAF during filter ripening. For example, Huck et al. (2002) reported a 
significant increase in oocyst passage during ripening tests conducted at the Britannia WTP in 
Ottawa, Canada. In that study, average C. parvum oocyst removal by CAF during filter ripening 
was consistently >3-log, but during this period, oocyst removal by CAF decreased by ~0.5 log on 
average, relative to stable operation. A similar experiment was conducted at the Metropolitan 
Water District of Southern California pilot plant, but significant differences between oocyst 
removal during filter ripening and stable filter operation were not observed (Huck, Coffey, 
Emelko, et al., 2002). The significance of the three ripening test results were first evaluated 
together. RIP-3 was then evaluated in isolation (Table 4-7). This was done due to the change in 
method that resulted in removal exceeding 3.0 log. 
Table 4-7. Comparison of Oocyst Removals during Stable Operation to those during Ripening 
using the Mann-Whitney U-test  
Experiments  p-value* W 
RIP-1 to RIP-3 
Shallow Bed 3.7E-07 343 
Deep Bed 2.3E-06 331 
RIP-3 
Shallow Bed 9.4E-04 113  
Deep Bed 0.005 105 
*when p-value < 0.05, reject null hypothesis: samples come from the same distribution, no difference in 
medians 
The results from the testing in Toronto indicate that at the 5% significance level, filter performance 
during ripening (RIP-3) and stable filter operation were different for both the shallow and deep 
bed filters. These results are consistent with what was reported in Ottawa by Huck et al. (2002). 
4.2.1.3 End-of-Run 
One end-of-run experiment was conducted. The conditions for this experiment are summarized in 
Table 4-8 and Figure 4-6.  Detailed results from these experiments are located in Appendix E.  
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END 8.9 40 -2.3 3.2 3.4 
C. parvum oocyst removals by shallow and deep bed CAF during end of run operation ranged from 
2.9 to 4.1 log (Appendix E). Oocyst removals by deep and shallow bed CAF during end of run 
conditions were significantly different from those observed during stable filter operation (5% 
significance level). Although the median oocyst removal was slightly lower, the results from the 
end of run experiment generally align with those observed during stable filter operation (in Section 
4.2.1.1). During the end of run experiment, the median C. parvum oocyst removals by shallow and 
deep bed CAF were >3.0-log, even when the filters had been in service for over 90 h. This is 
Figure 4-6. C. parvum Oocyst removal by CAF during Phase 2 end-of-run experiment (n=5) 
Shallow Bed       Deep Bed 
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consistent with a number of other end-of-run studies in the refereed literature (Emelko et al., 2003; 
Emelko, 2001; Huck et al., 2002). 
When compared to stable filter operation (Table 4-9), end-of-run in shallow and deep bed filters 
were statistically different as the p-values for both the shallow and deep bed filters were less than 
0.05. 
Table 4-9. Comparison of Oocyst Removals in Stable Operation to those End-of-Run using the 
Mann-Whitney U-test  
Experiment  p-value* W 
END-1 
Shallow Bed 0.016 98 
Deep Bed 0.003 107 
*when p-value < 0.05, reject null hypothesis: samples come from the same distribution, no difference in 
medians 
4.2.1.4 Hydraulic Surge  
A series of 6 sets of deep and shallow bed CAF experiments were conducted to investigate 



















SUR-1 13.1 40 N/A 4.2 4.8 
SUR-2 12.5 40 N/A 3.2 4.4 
SUR-3 4.3 40 N/A 4.7 4.7 
SUR -4 4.3 40 N/A 4.1 4.5 
SUR -5 5.3 40 N/A 4.5 4.7 
SUR -6 8.8 40 0.5 3.1 3.1 
C. parvum oocyst removals by shallow and deep bed CAF during hydraulic surge conditions 
ranged from 1.8 to 4.9 log (Appendix E). With the exception of SUR-6, oocyst removal by CAF 
Shallow Bed       Deep Bed 
Figure 4-7. C. parvum oocyst removal by CAF during Phase 2 hydraulic surges experiments, n=5 
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did not deteriorate during hydraulic surges relative to stable filter operation conditions. A statistical 
comparison between stable filter operation and the hydraulic surge tests was conducted (Table 
4-11). The surge experiments were evaluated as SUR-1 to SUR-5, SUR-6, and as the whole group 
(SUR-1 to SUR-6) because CAF performance appeared different during SUR-6. The results 
indicated that oocyst removals during SUR-1 to SUR-5 and SUR-1 to SUR-6 were not 
significantly different from those observed during stable filter operation (5% significance level). 
However, when the SUR-6 experiment was independently compared to stable filter operation, the 
difference in oocyst removal by CAF was statistically significant (p=0.001 and p=0.005 for 
shallow and deep bed filters respectively). These observations are consistent with one of three 
experimental observations reported by Emelko (2001) and Huck et al. (2002), which resulted in 
an average oocyst removals of 4.0-log by CAF, while the remainder of the reported results 
indicated more deteriorated (2.7- and 0.2-log; Emelko, 2001) performance. Those authors 
commented specifically about the difficulty in achieving reproducible oocyst removals by CAF 
during hydraulic surge experiments; in comparison, the results presented herein were substantially 
more consistent between the replicate experiments.   
Table 4-11. Comparison of Oocyst Removals in Stable Operation to those Hydraulic Surges 
using the Mann-Whitney U-test   
Experiment  p-value* W 
SUR-1 to SUR-5 
Shallow Bed 0.930 292 
Deep Bed 0.094 206 
SUR-6 
Shallow Bed 0.001 112 
Deep Bed 0.005 105 
SUR-1 to SUR-6 
Shallow Bed 0.290 404 
Deep Bed 0.550 311 
*when p-value < 0.05, reject null hypothesis: samples come from the same distribution, no difference in 
medians 
4.2.2 Effect of Temperature 
For the purpose of this investigation, experiments conducted at settled water temperatures 
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exceeding 10 °C were considered warm water experiments while those conducted at water 
temperatures below 10 °C were considered cold water experiments. Cold and warm water 
experiments were conducted for all operational conditions except during middle of run and sub-
optimal coagulation. Those two conditions, during Phase 2, were only evaluated at cold water 
temperatures. The results from shallow and deep bed filter removals for all experiments are 
summarized in a box and whisker plot (Figure 4-8). 
The red tones in Figure 4-8 indicate warm water conditions, when settled water was above 10 °C 
in the pilot plant, and the blue tones indicate conditions where the settled water temperature was 
below 10 °C. The analysis presented in Table 4-12 reveals that median C. parvum oocyst removals 
by CAF during hydraulic surge conditions were not statistically different from those observed 
during stable filter operation. As can be seen in Figure 4-8, there were eight instances when filter 
Shallow Bed – Warm       Deep Bed – Warm       Shallow Bed – Cold       Deep Bed – Cold  
Figure 4-8. C. parvum oocyst removal by CAF in warm and cold water during stable operation 




performance did not consistently exceed the 3-log oocyst removal target for well-operated 
treatment. This relatively deteriorated CAF performance can be attributed to specific operational 
conditions (e.g., sub-optimal coagulation, filter ripening) rather than water temperature.  
For example, as previously discussed, the filter ripening experiments that did not allow for 
adequate mixing of oocysts in filter influent streams prior to filter influent sampling suggested 
poor oocyst removals by CAF, although they were most likely attributable to the experimental 
configuration (which was modified for the last of the ripening experiments). The remainder of the 
instances when oocyst by CAF removal were less than 3-log were performed under sub-optimal 
coagulation conditions; thus, those results were expected. While the warm water temperatures 
were not particularly warm (highest was 13.1 °C), water temperature did not affect C. parvum 
oocyst removal by CAF under any circumstances; these results are consistent with similar data 
reported by Emelko (2001) and Huck et al. (2002), who saw no deterioration during stable filter 
operation at temperatures as low as 1 °C.  
Table 4-12. Comparison of C. parvum Oocyst Removal by CAF of Warm and Cold Water 
using the Mann-Whitney U-test 
Experiment Type  Filter Bed Depth p-value W 
SUR 
Shallow Bed 0.843 105 
Deep Bed 0.612 112 
*when p-value < 0.05, reject null hypothesis: samples come from the same distribution, no difference in 
medians 
4.2.3 Effect of Filter Bed Depth 
After the pilot-scale CAF experiments were completed, and water samples were processed and 
enumerated in the lab, oocyst removals by CAF were calculated using the time intervals outlined 
in Table 3-10. The sample collection times used to describe filter performance during the 
experiments were selected based on periods of consistent filter effluent oocyst counts, which 
indicated that pseudo steady state operational conditions had been achieved, and accounted for 
different travel distance in the columns above the media. The normality of these data was assessed 
using the Shapiro-Wilk test, Q-Q plots, and histograms (Appendix D). In many cases, the data 
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were not distributed in a manner consistent with the normal distribution, as would be expected 
during dynamic periods (ripening, hydraulic surges, etcs.) of CAF process operation. Accordingly, 
a non-parametric signed-rank statistical hypothesis test, the Mann-Whitney U-test, was utilized, 
and the shallow and deep bed CAF performance data were paired (Table 4-13).   
Table 4-13. Summary of Results from Shapiro-Wilk and Wilcoxon Tests to Evaluate Data Set 
Normality and Compare Filter Performance between Filter Bed Depths, Respectively 






w p-value w p-value 
MID40 
Shallow 0.93 0.11 
241 0.61 
Deep 0.90 0.028 
MID5/MID0 
Shallow 0.90 0.14 
107 0.26 
Deep 0.81 0.010 
END 
Shallow 0.87 0.25 
10 0.67 
Deep 0.79 0.073 
RIP 
Shallow 0.92 0.18 
65 0.051 
Deep 0.95 0.54 
SUR 
Shallow 0.90 0.0048 
291 0.019 
Deep 0.72 2.7E-06 
In general, these statistical analyses indicated that the shallow and deep bed filters did not perform 
differently from one another. Notably, there was no consistent trend in which the deviation from 
the median oocyst removal from the deep bed filter was lower than that in the shallow bed filter.  
One example in which the MID40-2 and MID40-4 experiments did suggest differences in 
performance is between the filter bed depths. In MID40-2, the deep bed filter outperformed the 
shallow bed filter, yet the spread in the data from the deep bed filter was much greater than that of 
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the shallow bed filter. For MID40-4, data from both the shallow and deep bed filters had similar 
spread, but the shallow bed filter outperformed the deep bed filter. 
The most notable exceptions to comparable performance between the two filter depths were the 
hydraulic surge (SUR) experiments. Oocyst removal by the shallow and deep filters was 
statistically different during the hydraulic surge investigations (p = 0.019; Figure 4-7, Figure 4-8), 
with deep bed filters consistently out-performing the shallow bed filters at these conditions.   
4.2.4 Zeta Potential  
To analyse zeta potential, samples were collected prior to oocyst addition to settled water (SW), 
after oocysts were added (SW + O), and finally, after the specified alum addition for the experiment 
(SW + O + alum). Each reading reflects the average of the three individual measurements from a 
single sample. Zeta potentials and average oocyst removals from Phase 1 and Phase 2 are 
summarized (Table 4-14).  
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Table 4-14. Zeta Potentials Measured in Phase 1 and 2 Experiments 






(SW + O) 






Phase 1      
P1 - 22.5b** -22.0 -16.9 -9.5 3.5 3.8 
P1 – 40a** -21.4 -11.8 -5.2 4.1 3.3 
P1 - 5 -12.2 -9.7 -15.6 1.2 1.2 
P1 – 40b** -16.0 -10.7 -7.1 3.6 3.8 
Phase 2      
MID40-3 -13.2 -5.4 0.1 5.4 5.4 
MID40-4 -8.2 -11.0 2.0 4.7 4.2 
MID5-5 -11.3 -6.3 -10.0 2.4 1.9 
MID0-6 -7.2 -7.4 -7.4* 1.3 0.9 
END -13.6 -10.1 1.3 3.2 3.3 
RIP-3 -11.8 -10.5 -2.3 3.0 3.4 
SUR-6 -16.3 -12.9 0.5 3.1 3.1 
 *no alum was added during this experiment, testing effect from no jar coagulation 
**a, b distinguish between repeat experiments from Phase 1, experiments were run on two separate 
occasions with the same alum dose 
Generally, settled water exhibited the lowest/most negative zeta potentials (-7.2 to -22.0 mV). 
These zeta potential measurements became less negative as oocysts (- 5.4 to -16.9 mV) and alum 
(2.0 to -15.6 mV) were added to the seed suspension. There were two instances in which the zeta 
potential decreased in the settled water (became less negative) after oocyst addition to the settled 
water (MID40-4 and MID0-6). These were the only experiments in which zeta potential was less 
negative than -10 mV in the settled water. The shift in zeta potential here to become more negative 
is likely due to the more negative nature of the oocysts, which were added to the settled water in 
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the high quantities necessary for demonstrating oocyst removal by CAF, that resulted in the 
majority of  SW + O readings tending towards -10 to -12 mV.  
Another trend in zeta potential was observed in the oocyst only seed suspension (SW + O) and 
following the alum addition. When 40 mg alum/L was added to the seed suspension, the zeta 
potential became less negative (closer to 0 mV) than it had been after oocysts were added to settled 
water (SW + O). The only experiments in which the zeta potential did not increase (i.e. become 
less negative) between oocyst addition and alum addition were the experiments when only 5 mg 
alum/L were added (P1 – 5 and MID5-5). These zeta potential data support the conclusions from 
Phase 1 (Table 4-2) that indicate the importance of adequate particle/oocyst destabilization by 
coagulation to achieve well operated CAF in which oocyst removal is maximized.  
The final seed suspension zeta potential values (SW + O + SW) and oocyst removal were plotted 
(Figure 4-9 and Figure 4-10). The shallow bed and deep bed filter results were separated to avoid 
overlapping points and clearly display the results from each filter depth. The zeta potential values 
for the seed suspensions were the same for the shallow and deep bed filter as both filters used a 
common seed suspension. Thus, the main difference between Figure 4-9 and Figure 4-10 is the 
change in oocyst removal achieved by the shallow and deep bed filters. Otherwise, the trends 












































Figure 4-10. Deep bed filter zeta potential vs oocyst removal for Phase 2 experiments 
The general trends in Figure 4-9 and Figure 4-10 indicate that all experiments in which coagulation 
was applied at doses above the typical plant dose (5 mg alum/L) resulted in >3 log oocyst removal. 
In addition, all experiments dosed at 40 mg alum/L produced zeta potentials of -7.1 mV or higher 
(i.e. less negative). There are three main data groupings in Figure 4-9 and Figure 4-10: 
1. P1 – 5, MID5 – 5, MID0 – 6, and P1 – 22.5; 
2. P1 – 40b, and MID0 – 6; and  
3. RIP – 3, END, and SUR – 6.  
The first set of points represent experiments in which sub-optimal coagulation (or no coagulation) 
resulted in oocyst removal below 3 log. P1 – 22.5 was an exception (Figure 4-9 and Figure 4-10) 
to this, but it was conducted at a coagulant dose that had previously resulted in poor oocyst 
removal; the first experiment conducted at 22.5 mg alum/L (P1 – 22.5a) resulted in average oocyst 






































added to this group on the basis that coagulant doses associated with these experiments had 
resulted in sub-optimal oocyst removal due to inadequate coagulation.  
This data grouping includes sub-optimal conditions which resulted in low oocyst removal and zeta 
potential values more negative than -4 mV. Zeta potential closer to the ZPC is expected (of course) 
as a result of more optimal coagulation (Bean et al., 1964; Bustamante et al., 2006; Cleasby et al., 
1963; Ghernaout, 2015; Gupta et al., 1973; Karamanet al., 1999; Neuman, 1981; Riddick, 1961; 
Xagoraraki & Harrington, 2004; Xu et al., 2006). These results compare favorably with Xagoraraki 
& Harrington (2004) who concluded that charge neutralization was not the dominant mechanism 
in coagulation, but rather the formation of aluminum hydroxide precipitates. As expected, Figure 
4-9 and Figure 4-10 illustrate the trend that relatively higher coagulant doses (and higher oocyst 
removal) are associated with zeta potentials near the ZPC. Alum speciation in the seed suspension 
was beyond the scope of this study but this could be done to further understand the relevant 
chemical phenomena that are occurring.  
The second pairing of points mentioned above, P1 – 40b and MID0 – 06, are of interest based on 
the similarities of their zeta potentials (-7.1 and -7.4 mV, respectively), but associated with 
different oocyst removals (above and below 3 log, respectively). The main difference between the 
two experiments here was the coagulant dose: P1 – 40b coagulated at 40 mg alum/L while MID0 
– 06 did not involve jar coagulation (i.e. no coagulant was added to the seed suspension). Here, 
interpretation of the net zeta potential is critical and it must be recognized that the oocysts were 
not adequately destabilized. This trend could be one reason the oocyst removals in P1 – 40b, and 
MID0 – 06 were so different; without the addition of at least some alum good oocyst removal will 
not occur (Dugan et al., 2001; Emelko, 2001; Huck, Coffey, Anderson, et al., 2002; Huck, Coffey, 
Emelko, et al., 2002; Masher & Hendricks, 1986). These data underscore the importance of 
recognizing that only net zeta potential is being evaluated and that the absolute value of zeta 
potential alone is inadequate for assessing particle/oocyst removal by CAF; rather, the zeta 
potential must be evaluated in parallel with understanding/ensuring that oocysts are being 
destabilized. 
The remaining experiments (RIP-3, END, and SUR-6, pairing 3) were not conducted under stable 
filter operation conditions. That said, all had near 0 mV zeta potential values in the final seed 
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suspension and achieved oocyst removal between 3.0 and 3.4 log in both filter bed depths. While 
these removals were lower than those observed during MID40-3 and MID40-4 (4.2 to 5.4 log, 
respectively) which had similar zeta potential values, they still exceed 3.0 log removal, the baseline 
for “well operated” filtration and “good” oocyst removal. It should be noted that more exhaustive 
analysis is need for definitive conclusions; nonetheless, the RIP and END experiments, (when 
compared with stable filter operation experiments described in Section 4.2.1), revealed significant 
deterioration in filter performance during these periods, consistent with previous investigations 
(Emelko et al., 2005; Huck, Coffey, Emelko, et al., 2002). In contrast to these previous literature, 
however, these data also indicated that most of these differences could be overcome as long as 
adequate particle/oocyst destabilization (i.e. coagulation) could be achieved.   
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Chapter 5 Conclusions, Implications, and Recommendations 
The overall goals of this study were to gain a better understanding of Cryptosporidium spp. oocyst 
removal by CAF in systems treating low turbidity, low TOC source water and provide strategies 
for improving CAF performance demonstrations. A protocol for conducting CAF performance 
demonstrations was developed and filter design (depth) and operational (sub-optimal coagulation, 
ripening, hydraulic surges, etc.) effects on C. parvum oocyst passage through CAF processes were 
investigated at pilot-scale. The utility of zeta potential for ensuring adequate protozoan pathogen 
removal by CAF in near-real-time was evaluated and the validity of utilizing high oocyst 
concentrations in filtration performance demonstrations to quantify the removal of lower/more 
environmentally relevant oocyst concentrations by CAF was confirmed. 
5.1 Conclusions 
Key findings from this research include the following: 
1. CAF remains a critical and effective barrier against protozoan pathogen (i.e. 
Cryptosporidium spp. and Giardia spp.) passage into treated drinking water. Here, mean 
C. parvum oocyst removals of 4.3- and 4.4-log (ranging from 3.5- to 4.9-log and 4.4- to 
5.0-log) were consistently achieved in shallow and deep bed pilot-scale filters respectively, 
during performance demonstrations conducted at optimal operating conditions (i.e., stable 
filter operation with appropriate jar coagulation of oocysts prior to filtration). These 
observations are consistent with what has been reported in other such investigations. 
2. Performance demonstrations in which high concentrations of oocysts are introduced to 
CAF influent streams to quantify their removal, must be conducted carefully to ensure 
coagulation is not a limiting factor. This is especially important when low turbidity, low 
TOC (high quality) source waters (typically <0.9 NTU and <2.3 mg TOC/L in the present 
investigation) are evaluated. Here, turbidity increased from an average of 0.22 NTU to 0.70 
NTU after oocysts were added to filter influent water to create the oocyst concentrations 
needed to demonstrate up to 5.0-log removal by CAF using direct membrane filtration and 
IFA staining for enumeration. These types of changes in filter influent quality during 
performance demonstrations have not been previously reported, likely because evaluations 
of C. parvum oocyst removal by CAF of low turbidity, low TOC source waters have 
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generally been considered to be less likely to contain sufficient quantities of oocysts to 
warrant expensive challenge testing. 
Notably, the consistently observed changes in filter influent water quality (turbidity) 
associated with oocysts addition to filter influent streams suggest that demonstrations of 
protozoan pathogen removal by CAF must be conducted with care to ensure that well-
operated/optimized filtration conditions are being represented. Thus, this work has two 
critical implications for conducting CAF performance demonstrations:  
(i) coagulation of seed suspensions (i.e., jar coagulation) is likely required to 
effectively neutralize/destabilize oocyst surface charge (through mechanisms of 
charge neutralization or enmeshment of oocysts in metal salt precipitates) during 
performance demonstrations in order to reflect well-operated CAF (even when 
oocysts are added to clarified water); and  
(ii) jar coagulation of oocyst seed suspensions may require higher coagulant doses 
than those used during regular treatment (i.e., when no oocysts are added to filter 
influent streams) when the performance of CAF of low turbidity, low TOC source 
waters is being evaluated. 
3. While it is commonly recognized that appropriate chemical pre-treatment is important for 
achieving well-operated CAF and protozoan pathogen removal, this work demonstrated 
that it is especially critical to ensuring optimal oocyst removal by CAF in systems treating 
high quality source water. In these situations, relatively small shifts in source water quality 
can substantially affect both coagulation regime (i.e., the primary mechanism(s) by which 
particles are destabilized to enable their removal by CAF: charge neutralization, sweep floc 
coagulation, enmeshment in metal salt precipitate) and efficacy. Here, excellent oocyst 
removals (3.7-log on average) were achieved in all cases (i.e., regardless of filter design 
[depth] and operational conditions [hydraulic surge, ripening, end-of-run, ripening, 
increased loading rate, water temperature]) as long as appropriate chemical pre-treatment 
was implemented. When adequate jar coagulation was not implemented, oocyst removals 
by CAF decreased to 1.3-log on average.  
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These observations underscore the importance of coagulation as a critical control for 
ensuring protozoan pathogen removal by CAF in systems treating low turbidity, low TOC 
source waters. These results markedly differ from reports from systems with higher source 
water TOC and turbidity, in which chemical pre-treatment had a less significant impact on 
oocyst passage through CAF than period in the filter cycle (e.g., end-of-run filtration, 
ripening. This difference underscores the importance of coagulation regime and its 
relationship to filter performance.  
4. To further the previous conclusion, jar coagulation of oocysts was identified as the most 
important factor pertaining to the deterioration of filter performance as evidenced by 
MID5-5 and MID0-6. In this research, filter performance during sub-optimal and no jar 
coagulation conditions resulted in removals of oocysts that were significantly impaired (< 
3.0 log) as compared to stable filter operation. These results quantitatively speak to the 
differences in oocyst log removal when particle/oocyst destabilization was insufficient in 
the seed suspension. 
5. In addition to sub-optimal coagulation, ripening and end of run experiments resulted in a 
deterioration of oocyst removal (~0.5 log decrease on average) by CAF. These results have 
been previously observed by others (Huck, Coffey, Emelko, et al., 2002) where a 
deterioration in filter performance was observed while overall oocyst removals remained 
above 3.0 log. This further underscores the importance of proper coagulation as a filter 
operational conditions did not contribute to oocyst passage that resulted in less than 3.0 log 
removal and were not a limiting factor in CAF performance of oocyst removal.  
6. Although filter effluent turbidity is a good indicator of treatment performance, it is not 
necessarily a good indicator of C. parvum oocyst removal by CAF, in systems with low 
turbidity, low TOC source water, such as the one studied herein. In the present 
investigation, a very wide range of oocyst removals (ranging from 0.8- to 5.0-log) by pilot-
scale CAF was observed when coagulant dose and associated oocyst surface charge 
(indicated by zeta potential) in the seed suspension was varied, despite filter operation that 
would be considered “well-operated” with effluent turbidities that were always less than 
0.2 NTU and below 0.1 NTU the majority of the time. Such a wide range of oocyst 
80 
 
removals by “well-operated” filters during periods of stable operation has not been 
previously reported.  
Notably, these observations have two important implications: 
(i) the criteria for what constitutes “well-operated” treatment (Health Canada, 2017; 
MOECP, 2018) for ensuring protozoan pathogen removal by CAF must be further 
clarified and validated; and,  
(ii) additional support infrastructure/tools should be developed and validated to better 
ensure adequate protozoan pathogen removal by CAF in (near) real-time. 
7. Zeta potential analysis is useful for ensuring optimal CAF performance in systems treating 
low turbidity, low TOC source water that requires sweep floc coagulation for adequate 
particle destabilization. Here, zeta potential values between -5 mV and 0 mV during 
chemical pre-treatment consistently resulted in mean C. parvum oocyst removals of 3.0-
log or greater.  
Given that low filter effluent turbidities (< 0.1 NTU) alone were inadequate for ensuring 
oocyst removal during the pilot-scale investigations reported herein, this work suggests 
that a combination of zeta potential analysis and turbidity monitoring may offer better 
control of CAF as a barrier against C. parvum oocyst passage into treated drinking water. 
This combination is likely relevant for systems in which either enmeshment or charge 
neutralization are the dominant mechanisms of coagulation.  
8. Both the deep and shallow filter bed designs (750 mm and 500 mm, respectively) 
investigated herein can achieve excellent (i.e., >3-log) C. parvum oocyst removal at 
optimal operating conditions. The statistical comparisons between the filters revealed that 
the deep and shallow bed configurations performed similarly with the exception of during 
hydraulic surges during which the deep bed filter outperformed the shallower 
configuration. Thus, in some instances a deeper bed filter design may offer additional 
operational resilience when influent water quality changes or other operational challenges 
(e.g., hydraulic surges) occur. 
9. High oocyst concentrations can be used in filtration performance demonstrations to 
quantify the removal of lower/more environmentally relevant oocyst concentrations by 
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CAF, under the conditions investigated herein. This result is in contrast to another study 
that reported that C. parvum oocyst removal by CAF was affected by influent oocyst 
concentration (Assavasilavasukul et al., 2008). In the present investigation, two filter 
influent oocysts concentrations were investigated: ~102 oocysts/L (which is a lower, more 
environmentally relevant oocyst concentration (LeChevallier & Norton, 1995; 
LeChevallier, Norton, & Lee, 1991) and ~105 oocysts/L (which enabled performance 
demonstrations in which up to 5.0-log oocysts removal by CAF could be quantitatively 
evaluated using direct membrane filtration and IFA staining). Notably, similar removals of 
oocysts by CAF were observed, irrespective of influent oocyst concentration.  
This result has two critical implications:  
(1) it illustrated that filter performance demonstrations in which high concentrations 
of oocysts are introduced to CAF influent streams to quantify their removal are a 
valid approach for quantitatively evaluating oocyst removal by CAF; and 
(2) it validated the appropriateness of the jar coagulation procedure used during the 
pilot-scale investigations because comparable results were achieved between the 
low and high influent oocyst concentration experiments, which also required 
different coagulant doses due to the associated changes in water quality that resulted 
from oocyst addition to the filter influent streams. 
10. Temperature ranged from 4.1 to 13.1°C over the course of the research, and cold water 
temperature was determined as water temperature at and below 10°C. The majority of the 
experiments were conducted during cold water temperatures (thirteen of sixteen) and 
achieved greater than 3.0 log removal, with the exception of MID5-5 and MID6-0 where 
sub-optimal and no jar coagulation were present. These results showed that water 
temperature did not affect C. parvum oocyst removal by CAF under any circumstances 
other than during suboptimal jar coagulation, which is consistent with similar data reported 





The following recommendations for operations and management, and further research are 
proposed based on the conclusions of this work. 
5.2.1 Operations and Management 
The following recommendations are proposed for conducting performance demonstrations of 
oocyst removal by CAF of high quality source water: 
1. Monitor clarified water/filter influent zeta potential to ensure adequate charge 
neutralization prior to filtration; 
2. Jar coagulate seed suspensions of C. parvum oocysts (or other particles) to ensure that 
operational conditions during performance demonstrations reflect “well-operated” 
treatment—this is especially critical when oocyst addition significantly changes filter 
influent water quality; and,  
3. Respond as quickly as possible when sub-optimal coagulation is evident—zeta potential 
analysis may be more sensitive than turbidity in identifying this situation. 
 
5.2.2 Research 
Several suggestions for improvement or further areas to study are listed below to build upon the 
findings of this thesis research.  
1. More data related to non-ideal operational conditions should be collected (specifically 
during hydraulic surges, ripening, and end-of-run conditions) to build a more 
comprehensive understanding of zeta potential analysis use at these conditions. 
2. Perform additional confirmatory studies using more environmentally relevant/lower 
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Appendix A – Summary of Full- and Pilot-Scale Water 


























1 - Pilot 
Exp. Flow 
Rate Filter 
3 - Pilot 
Total Flow 
Rate - Full 
Scale 
Units     °C  °C     mg/L mg/L mg/L L/min L/min L/min 
Phase 1 Experiments 
11-May-17 P1 – 22.5a 7.9 6.4 7.5 7.9 22.5 5.0 5.0 1.49 1.48 2.9 
08-Jun-17 P1 – 22.5b 12.2 11.1 7.4 7.7 22.5 5.5 5.0 1.48 1.49 3.4 
09-Jun-17 P1 – 40a 11.7 9.9 7.4 7.7 40 5.5 5.0 1.47 1.48 3.3 
02-Aug-17 P1 – 5 16.2 14.0 7.2 7.7 5 5.5 5.0 1.48 1.48 4.5 
03-Aug-17 P1 – 40b 14.8 11.9 7.2 7.6 40 5.5 4.5 1.48 1.48 4.2 
Phase 2 Experiments 
11-Dec-17 RIP-1 12.0 4.8 6.8 7.7 40  4.0  4.0 0.68 0.67 3.2 
09-Jan-18 RIP-2 4.1 2.5 7.0 7.7 40  4.0 5.0 0.63 0.62 3.5 
29-May-18 RIP-3 9.1 6.7 7.2 7.7 40  4.5 4.5 0.68 0.70 3.0 
05-Oct-17 MID40-1 16.0 15.9 7.2 7.8 40  5.5 * 0.84 0.67 3.5 
23-Oct-17 MID40-2 9.7 6.6 7.0 7.6 40  4.5 * 0.78 0.67 3.5 
06-Mar-18 MID40-3 4.5 2.8 6.9 7.7 40  4.5  4.5 0.69 0.69 3.3 
19-Mar-18 MID40-4 4.6 2.6 6.9 7.7 40  4.5  * 0.68 0.74 5.8 
10-Apr-18 MID5-5 4.9 2.9 7.0 7.7 5  4.3  4.5 0.68 0.79 5.6 
23-Apr-18 MID0-6 5.0 3.1 7.1 7.7 0  5.0  5.0 0.68 0.77 4.0 
29-May-18 END-1 9.1 6.7 7.2 7.7 40  4.5 4.5 0.68 0.70 3.0 
13-Nov-17 SUR-1 13.1 5.1 6.8 7.7 40  4.8  4.0 0.70 0.72 3.3 
28-Nov-17 SUR-2 12.5 2.2 6.9 7.9 40  6.0  * 0.70 0.69 3.3 
22-Jan-18 SUR-3 4.3 2.1 6.8 7.9 40  4.3 3.9 0.71 0.71 3.0 
06-Feb-18 SUR-4 4.3 2.3 6.9 7.7 40  4.5 4.5 0.69 0.69 3.3 
21-Feb-18 SUR-5 5.3 2.2 6.9 7.6 40  4.0 4.5 0.68 0.68 3.2 
19-Jun-18 SUR-6 8.9 6.7 7.2 7.7 40  4.5 4.5 0.67 0.70 3.0 
Method 1623 Experiments 
16-Jul-18 -- 11.0 7.7 7.2 7.6 20 4.5 4.5 0.67 -- 4.6 




Appendix B – Modified USEPA (2005) Method 1623.1 
ColorSeed™ Recovery Procedure: 
1. Removed Envirochek®HV capsule from packaging and labelled with sample location. 
2. Connected the capsule inlet to a flow meter using tubing. Positioned the pump on the 
upstream side of flow meter connecting it to filtered water. 
3. Connected the capsule outlet to the filtered water tubing. This tube drained into a waste 
drain.  
4. Turned the pump on and maintained a flow rate of ~ 2 LPM, and allowed approximately 
1 L of filtered water to flow through the capsule prior to adding ColorSeed™. 
5. Turned off the pump and placed a clamp on both the inlet and outlet tubing to stop water 
from draining from the capsule. The filter cartridge was full. 
6. Placed the capsule in an upright position using a ring stand with inlet pointing upward. 
7. Carefully removed the outlet tubing and allowed for water to drain to the top of pleated 
white membrane, and reattached the clamp. 
8. Added 2 mL of Tween into the ColorSeed™ vial, replaced the cap and vortexed for 20 
seconds at maximum speed. 
9. Removed the cap and poured the ColorSeed™ into the capsule inlet, ensured it all went 
onto the filter. 
10. Added 3 mL of filtered water to the ColorSeed™ tube.  Replaced cap and vortex for 20 
seconds at maximum speed. 
11. Removed cap and poured the vial content into the capsule inlet. 
12. Repeated the above two steps (rinsed vial with 3 mL filtered water) two more times 
(three total). Ensured the water level remained above the pleated white membrane if not 
using the cartridge immediately. 
13. If the experiment required more than one cartridge, prepared all cartridges with 
ColorSeed™. Made sure the water level remained above the pleated white membrane and 




1. Connected the capsule inlet to a flow meter using tubing. The pump went on the upstream 
side of flow meter connecting it to filtered water source. 
2. Connected the capsule outlet to the filtered water tubing. Had this tube drain into a waste 
drain.  
3. Turned the pump on and maintained a flow rate of ~ 2 LPM.  
4. Collected effluent in a bucket and used this as the source of filtered water that pumped 
through the cartridge. 
5. Monitored the flow rate and total sample volume filtered.  
6. When the required sample volume was filtered, turned off the pump, removed tubing 
from the capsule outlet, and replaced it with a blue vinyl cap.  
7. To ensure the water level remained above the pleated white membrane, turned the pump 
on and allowed the cartridge to fill before turning off the pump. Placed the other blue 
vinyl cap on the inlet side after removing the tubing. 
8. Recorded the time and sample volume filtered on the cartridge. 
9. Placed the capsule in a cooler for transport to the lab. 
10. Refrigerated sample at 2-8 °C if not proceeding with Sample Elution. 
If multiple cartridges are being used, quickly moved the inlet tubing to the second cartridge once 
it is removed from the previous cartridge.   
97 
 
Appendix C – Recovery Testing 
Ripening Recovery Study  
Extra tubing was required during ripening experiments in order to capture the ripening period of 
the filter. The additional tubing seeded closer to the top of the filter but provided more 
opportunities for oocysts loss. A recovery study was conducted on the additional seeding and 
influent sample tubing to quantify losses during this portion experimental work.  The tubing used 
during ripening experiments was more than double the length of the tubing from the seed 
suspension to the filter bed, and from the filter bed to influent sampling port.  
The recovery test was conducted using the same framework as the ripening experiment in order to 
mimic conditions. A seed suspension was created to test the influent length of tubing while influent 
samples from previous (non-ripening) experiments were used to evaluate losses through the 
influent sample length of tubing. A sample volume of 1 mL was initially used during 
immunofluorescence assay to numerate samples collected from the seeding tubing but slide counts 
were too numerous to count. The volume used during this process was modified to 0.2 mL for 
reasonable counts. Results from the recovery study are in Table A-1. 









1 0.02 25,400,000 19,750,000 
2 0.02 11,800,000 
3 0.02 3,950,000 
4 0.02 14,150,000 
5 0.02 13,000,000 
6 0.02 16,850,000 
7 0.02 11,600,000 
8 0.02 15,400,000 
9 0.02 16,400,000 
Mean   13,000,000 
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A similar approach was taken to enumerate the samples taken from the influent sampling tubing. 
A sample volume of 1 mL was processed from 10 different samples. The results are in Table A-2. 









1 1 60,400 50,000 
2 1 40,000 
3 1 40,000 
4 1 35,000 
5 1 43,000 
6 1 52,000 
7 1 43,000 
8 1 31,000 
9 1 34,000 
10 1 23,000 
Mean   39,000 
The results in Table A-1 and Table A-2 indicate that the tubing was not the cause for the low 
oocyst removals calculated during RIP-01 and RIP-02.  The losses listed in the tables were not the 
same order of magnitudes as the difference between RIP-01/-02 and the experiments conducted 
prior to them. Losses from tubing were ruled as the cause for low oocyst removal during the initial 
ripening experiments. 
Lab Equipment Recovery Study  
Recovery testing was also completed to determine losses from each set of lab procedures used to 
process and enumerate samples collected during Harris WTP experiments. First, a dilution from 
the stock suspension of Cryptosporidium oocysts was enumerated using a haemocytometer. This 
was completed for a more accurate representation of the dilution. The aim of the dilution was 100 
oocysts per 1/1,000 mL (1 μL) on the haemocytometer which ultimately resulted in an average 
concentration of 84 oocysts/μL in the dilution. Following this, influent and effluent solutions were 
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made to mirror volumes processed during typical experiments while maintaining concentration of 
84 oocysts/μL.  
The lab methods that were evaluated for recovery testing were the influent and effluent manifold 
methods, the syringe influent method, and the glass manifold effluent method. All samples and 
test equipment were prepared to imitate sample collection and lab procedures. More specifically, 
water was collected from the respective ports from the pilot plant in Toronto to ensure the same 
water matrix was used and eluting solution was added to each sterilized bottle prior to oocyst 
addition. A volume of 3 mL was selected for the influent samples and 300 mL for the effluent 
samples. Once completed, 10 trials were run using each of the four methods mentioned above. The 
results from the study are below in Table A-3.  
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Table A-3. Lab Recovery test results for influent and effluent lab procedures 
Trial 












oocysts/L oocysts/L oocysts/L oocysts/L 
1 96,000 28,056 667 9,333 281 117 230 
2 84,000 1,333 10,000 97 190 
3 122,000 1,000 4,667 213 213 
4 106,000 2,667 13,667 287 203 
5 74,000 1,333 15,000 150 187 
6 80,000 14,667 23,667 163 143 
7 84,000 1,000 11,667 163 137 
8 80,000 2,333 10,667 150 247 
9 84,000 3,667 2,333 117 163 
10 54,000 3,000 1,000 127 160 
11 86,000 N/A N/A N/A N/A N/A N/A 
12 60,000 N/A N/A N/A N/A N/A N/A 
Mean 84,167 28,056 3,167 10,200 281 158 187 
Recovery  N/A N/A 11% 36% N/A 56% 67% 
The results from Table A-3 show better recovery in the effluent methods than the influent methods. 
The results from the influent manifold method may not be representative of the actual test results 
as the majority of the tests conducted using this method, experiments prior to October 5, 2017, 
used less than 1 mL sample volume which was a volume small enough not to come into contact 
with the rough walls of the smaller manifold which were introduced during April 2017 
experiments. This is supported by the similar influent counts enumerated over the time period the 
influent manifold was used and the syringe technique used as well as results from August 
experiments when both influent methods were used to enumerate the influent samples. The losses 
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from the influent manifold system were therefore attributed to the surface roughness that resulted 
from the parts made at the University of Waterloo. These parts were made to accommodate the 
smaller diameter filter membrane used for influent samples while still using the same manifold 
















Deep Bed Filter Histograms 
Oocyst Removal (log10) Oocyst Removal (log10) 
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  Shallow Bed Filter Histograms 
Oocyst Removal (log10) Oocyst Removal (log10) 
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Appendix E – Phase 1 and Phase 2 Results 
Date: May 11, 2017 
ID: P1 – 22.5a 
Type of Experiment: Phase 1 Pilot-scale CAF Performance Demonstration 
 
Filter Plant 

















Deep Harris deep (0.48) 22.5mg/L 5 
 




























0 01 3 2 667 200 TNTC 519 -- 
02 3 0 0 100 0 0 
03 
 
200 135 675 
15 01 3 4 1,333 200 TNTC 672 0.05 
02 3 3 1,000 200 281 1,405 
30 01 3 2 667 200 TNTC 608 0.2 
02 3 2 667 200 62 310 
45 01 3 32 10,667 200 457 2,285 1.5 
02 3 233 77,667 200 55 275 
60 01 3 278 92,667 200 32 160 2.6 
02 3 268 89,333 200 66 330 
75 01 3 201 67,000 200 43 215 2.4 
02 3 127 42,333 200 52 260 
































0 01 3 0 0 200 32 160 -- 
02 3 7 2,333 200 273 1,365 
03 3 0 0 100 0 0 
15 01 3 22 7,333 200 28 140 0.7 
02 3 3 1,000 200 336 1,680 
30 01 3 12 4,000 200 8 40 1.3 
02 3 2 667 200 174 870 
03 3 24 8,000 
 
04 3 65 21,667 
 
45 01 10 125 12,500 100 28 280 1.7 
02 3 97 32,333 200 78 390 
03 3 7 2,333 
 
60 01 3 35 11,667 200 79 395 1.0 
02 3 40 13,333 200 307 1,535 
03 3 4 1,333 
 
75 01 3 69 23,000 200 20 100 2.1 
02 3 191 63,667 200 83 415 




Date: June 8, 2017 
ID: P1 – 22.5b 


















Shallow  Harris 
regular 
(0.3) 


































0 01 6 0 0 700 TNTC -- -- 
02 6 2 333 
03 6 0 0 
15 01 6 17 2,833 700 1 1 3.4 
02 6 23 3,833 
30 01 1 10 10,000 700 3 4 3.5 
02 1 18 18,000 
45 01 0.6 0 0 700 3 4 3.8 
02 0.6 0 0 
03 0.6 35 58,333 
04 0.6 32 53,333 
60 01 0.6 2 3,333 700 13 19 3.2 
02 0.6 0 0 
03 0.6 39 65,000 
04 0.6 31 51,667 
75 01 0.6 12 20,000 700 1* 1 >4.0 
02 0.6 7 11,667 































0 01 6 0 0 700 2 3 -- 
02 3 0 0 
15 01 6 3 500 700 1* 1 >3.1 
02 3 9 3,000 
30 01 6 199 33,167 700 3 4 3.9 
02 3 126 42,000 
45 01 1 5 5,000 100 1 10 3.8 
02 6 444 74,000 700 1 1 
60 01 6 293 48,833 100 3 30 3.5 
02 0.6 33 55,000 700 5 7 
75 01 6 432 72,000 700 1* 1 > 4.7 
02 0.6 44 73,333 





Date: June 9, 2017 
ID: P1 – 40a   
Type of Experiment: Phase 1 Pilot-scale CAF Performance Demonstration 
 
Filter Plant 


















Deep Harris deep (0.48) 40mg/L 5 
 
























0 01 6 1 167 700 0 0 -- 
02 6 3 500 
15 01 6 19 3,167 700 3 4 2.9 
02 6 23 3,833 
30 01 1 30 30,000 700 2 3 4.0 
02 0.6 20 33,333 
45 01 0.6 1 1,667 700 2 3 3.9 
02 0.6 29 48,333 
60 01 0.6 0 0 700 2 3 4.2 
02 0.6 51 85,000 
75 01 0.6 4 6,667 700 2 3 4.1 






























0 01 6 0 0 700 1 1 -- 
02 3 0 0 
15 01 6 5 833 700 1 1 3.3 
02 3 13 4,333 
30 01 6 128 21,333 700 3 4 4.0 
02 3 174 58,000 
45 01 6 366 61,000 700 1 1 4.6 
02 0.6 36 60,000 
60 01 6 385 64,167 100 9 90 2.8 
02 0.6 16 26,667 700 39 56 
75 01 6 35 5,833 700 1 1 4.6 




Date: August 2, 2017 
ID: P1 – 5 
Type of Experiment: Phase 1 Pilot-scale CAF Performance Demonstration 
 
Filter Plant 


















Deep Harris deep (0.48) 40mg/L 5 
 
























0 01 1 0 0 100 3 30 -- 
02 6 0 0 100 0 0 
15 01 6 1 167 10 1* 1 >3.4 
02 3 10 3,333 10 1* 1 
03 6 23 3,833 
   
30 01 6 64 10,667 10 4 400 1.9 
02 3 110 36,667 10 2 200 
45 01 6 160 26,667 10 11 1,100 1.6 
02 3 220 73,333 10 7 700 
03 3 31 10,333 
   
60 01 0.1 2 20,000 100 485 4,850 0.7 
02 1 11 11,000 10 28 2,800 
03 3 114 38,000 
   
04 3 33 11,000 
   
75 01 3 253 84,333 10 27 2,700 1.3 
02 6 268 44,667 10 18 1,800 
03 3 8 2,667       
*actual slide count is 0 but changed to 1 to calculate a conservative oocyst removal 
 
Deep      



























   
10 1 100 -- 
02 6 0 0 10 0 0 
15 01 6 6 1,000 10 1 100 0.7 
 02 6 0 0 10 1 100 
30 01 3 52 17,333 10 3 300 1.6 
 02 3 91 30,333 10 8 800 
45 01 3 35 11,667 10 24 2400 1.1 
 02 3 185 61,667 10 39 3900 
60 01 3 61 20,333 10 15 1500 0.9 
 02 3 59 19,667 10 40 4000 
75 01 3 328 109,333 10 12 1200 1.3 






Date: August 3, 2017 
ID: P1 – 40b 
Type of Experiment: Phase 1 Pilot-scale CAF Performance Demonstration 
 
Filter Plant 











Shallow Harris regular (0.3) 5mg/L 5 1050mL 
between both 
5.00E+07 
Deep Harris deep (0.48) 5mg/L 5 
 


























0 01 6 10 1,667 700 1 1 2.8 
02 6 1 167    
15 01 6 27 4,500 700 1 1 3.2 
02 6 2 333    
30 01    700 5 7 3.6 
02 6 57 9,500    
03 3 122 40,667    
45 01 3 136 45,333 10 0 0 4.0 
02 6 34 5,667 700 4 6 
60 01 3 130 43,333 100 2 20 3.2 
02 6 9 1,500 700 4 6 
75 01 3 102 34,000 700 1 1 4.1 





Deep      


























0 01 6 0 0 700 0 0 0.0 
02 6 0 0      
15 01 6 3 500 700 1 1 2.4 
02 6 1 167      
30 01 3 99 33,000 700 2 3 4.0 
02 3 60 20,000      
45 01 3 11 3,667 700 2 3 3.3 
02 3 23 7,667      
60 01 3 130 43,333 400 2 5 3.7 
02 3 12 4,000      
75 01 3 72 24,000 700 1* 1 >4.2 
02             











Date: December 11, 2017 
ID: RIP -1 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
5.00E+05 
Deep Harris deep (0.48) 40mg/L 5 
 


























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
5 01 1 298 298,000 700 6 9 4.6 
02 1 315 315,000 
10 01 1 1 1,000 700 8 11 2.2 
02 1 3 3,000 
15 01 1 11 11,000 700 8 11 3.0 
02 1 10 10,000 
20 01 1 5 5,000 700 6 9 2.8 
02 1 5 5,000 
25 01 1 11 11,000 100 2 13 3.0 
02 1 14 14,000 700 4 
30 01 1 3 3,000 700 6 9 2.7 




Deep      


























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
5 01 1 1 1,000 700 1 1 3.2 
02 1 4 4,000 
10 01 1 1 1,000 700 1 1 3.6 
02 1 10 10,000 
15 01 1 2 2,000 700 8 11 2.6 
02 1 8 8,000 
20 01 1 8 8,000 700 8 11 2.9 
02 1 7 7,000 
25 01 1 0 0 700 2 3 2.2 
02 1 1 1,000 
30 01 1 4 4,000 700 5 7 2.6 




Date: January 9, 2018 
ID: RIP -2 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
4.60E+06 
Deep Harris deep (0.48) 40mg/L 5 
 


























0 01 6 0 0 700 0 0 0.0 
02 6 1 167 
5 01 1 0 0 700 2 3 1.9 
02 2 1 500 
10 01 1 0 0 700 4 6 1.6 
02 2 1 500 
15 01 1 0 0 700 8 11 1.3 
02 2 1 500 
20 01 2 3 1,500 700 3 4 2.5 
02 2 2 1,000 
25 01 2 2 1,000 700 5 7 2.2 
02 2 2 1,000 
30 01 2 2 1,000 700 4 6 2.3 






























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
5 01 1 4 4,000 700 1 1 3.4 
02 1 3 3,000 
10 01 1 0 0 700 1 1 -- 
02 1 0 0 
15 01 1 1 1,000 700 1 1 2.9 
02 1 1 1,000 
20 01 1 3 3,000 700 2 3 2.9 
02 1 2 2,000 
25 01 1 2 2,000 100 1 6 2.5 
02 1 2 2,000 
30 01 1 3 3,000 700 3 4 2.8 





Date: May 29, 2018 
ID: RIP – 3 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 













Shallow Harris regular (0.3) 40mg/L 5 130L 
between  
2.87E+07 
Deep Harris deep (0.48) 40mg/L 5 
 

























0 01 6 64 10,667 700 25 36 0.0 
02 10 0 0 
5 01 1 0 0 689 1 1 -- 
02 2 0 0 
10 01 1 33 33,000 700 37 53 2.7 
02 2 48 24,000 
15 01 1 66 66,000 700 33 47 3.1 
02 2 92 46,000 
20 01 1 84 84,000 700 21 30 3.4 
02 2 121 60,500 
25 01 1 62 62,000 700 60 86 2.9 
02 2 117 58,500 
30 01 1 19 19,000 700 18 26 3.2 






























0 01 6 0 0 700 9 13 0.0 
02 10 0 0 
5 01 1 25 25,000 700 13 19 3.2 
02 2 77 38,500 
10 01 1 35 35,000 700 11 16 3.4 
02 2 71 35,500 
15 01 1 162 162,000 700 62 89 3.3 
02 2 337 168,500 
20 01 1 80 80,000 700 20 29 3.6 
02 2 220 110,000 
25 01 1 79 79,000 700 22 31 3.4 
02 2 160 80,000 
30 01 1 27 27,000 700 8 11 3.3 














Date: October 5, 2017 
ID: MID40-1 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 750mL 
btwn  
2.92E+06 
Deep Harris deep (0.48) 40mg/L 5 
 





























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
15 01 6 0 0 700 0 0 0.0 
02 6 0 0 
30 01 3 49 16,333 700 3 4 4.0 
02 3 183 61,000 
45 01 3 270 90,000 700 8 11 3.7 
02 3 48 16,000 
60 01 3 124 41,333 700 2 3 4.6 
02 3 525 175,000 
75 01 3 142 47,333 700 16 23 3.4 





























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
15 01 6 0 0 700 0 0 0.0 
02 6 0 0 
30 01 3 120 40,000 700 1* 1 >4.3 
02 3 68 22,667 
45 01 3 62 20,667 100 2 11 3.8 
02 3 352 117,333 700 2 
60 01 3 182 60,667 700 2 3 4.2 
02 3 60 20,000 
75 01 3 147 49,000 700 3 4 4.1 
02    




Date: October 23, 2017 
ID: MID40-2 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 















Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
2.02E+06 
Deep Harris deep (0.48) 40mg/L 5 
 
Shallo



























0 01 6 0 0 700 0 0 0.0 
 02 6 0 0 
15 01 6 3 500 700 1* 1 >2.5 
 02 6 3 500 
30 01 6 209 34,833 700 1* 1 >4.3 
 02 6 151 25,167 
45 01 3 148 49,333 700 3 4 3.9 
 02 6 109 18,167 
60 01 3 547 182,333 700 2 3 4.6 
 02 6 424 70,667 
75 01 3 141 47,000 700 3 4 4.3 
 02 3 398 132,667 
90 01 3 325 108,333 700 4 6 4.3 
 02 3 391 130,333 
105 01 3 240 80,000 700 4 6 4.4 
02 3 544 181,333 





























0 01 6 0 0 700 0 0 0.0 
 02 6 0 0 
15 01 6 1 167 700 1 1 2.2 
 02 6 2 333 
30 01 6 100 16,667 700 1* 1 >4.0 
 02 6 68 11,333 
45 01 6 430 71,667 700 1* 1 >4.6 
 02 6 244 40,667 
60 01 6 759 126,500 700 2 3 4.7 
 02 3 495 165,000 
75 01 3 102 34,000 700 2 3 4.2 
 02 3 173 57,667 
90 01 3 222 74,000 700 1* 1 >4.9 
 02 3 446 148,667 
105 01 3 277 92,333 700 1* 1 >4.8 
02 3 279 93,000 




Date: March 6, 2018 
ID: MID40-3 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 













Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
4.48E+07 
Deep Harris deep (0.48) 40mg/L 5 
 
























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
15 01 1 0 0 700 1* 1 >2.5 
02 1 1 1,000 
30 01 1 14 14,000 700 1 1 4.1 
02 1 18 18,000 
45 01 1 43 43,000 700 1 1 4.5 
02 1 53 53,000 
60 01 1 68 68,000 700 1* 1 >4.6 
02 1 57 57,000 
75 01 1 89 89,000 700 1* 1 >4.8 
02 1 85 85,000 
90 01 1 91 91,000 700 1* 1 >4.8 
02 1 86 86,000 
105 01 1 100 100,000 700 1* 1 >4.9 
02 1 100 100,000 
































0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
15 01 1 2 2,000 700 1 1 3.2 
02 1 2 2,000 
30 01 1 27 27,000 700 1 1 4.3 
02 1 30 30,000 
45 01 1 36 36,000 700 1* 1 >4.4 
02 1 31 31,000 
60 01 1 52 52,000 700 1* 1 >4.5 
02 1 44 44,000 
75 01 1 63 63,000 700 1* 1 >4.6 
02 1 57 57,000 
90 01 1 97 97,000 700 1 1 4.8 
02 1 86 86,000 
105 01 1 101 101,000 700 1* 1 >4.9 
02 1 107 107,000 




Date: March 19, 2018 
ID: MID40-4 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 


















Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
4.35E+07 
Deep Harris deep (0.48) 40mg/L 5 
 
Shallo




























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
15 01 1 3 3,000 700 1 1 3.3 
02 1 3 3,000 
30 01 1 11 11,000 700 3 4 3.4 
02 1 12 12,000 
45 01 1 30 30,000 700 2 3 4.0 
02 1 31 31,000 
60 01 1 53 53,000 700 1* 1 >4.5 
02 1 44 44,000 
75 01 1 64 64,000 700 1 1 4.6 
02 1 60 60,000 
90 01 1 77 77,000 700 1 1 4.7 
02 1 78 78,000 
105 01 1 82 82,000 700 1* 1 >4.8 
02 1 85 85,000 






































15 01 1 1 1,000 700 1 1 >2.5 
02 1 0 0 
30 01 1 2 2,000 700 2 3 3.5 
02 1 16 16,000 
45 01 1 9 9,000 700 1 1 3.6 
02 1 3 3,000 
60 01 1 6 6,000 700 3 4 3.7 
02 1 38 38,000 
75 01 1 39 39,000 700 
   
02 1 40 40,000 
90 01 1 42 42,000 700 1 1 4.5 
02 1 42 42,000 
105 01 1 51 51,000 700 1 1 4.5 




Date: April 10, 2018 
ID: MID5-5 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 


















Shallow Harris regular (0.3) 5mg/L 5 1130L 
between  
4.45E+07 
Deep Harris deep (0.48) 5mg/L 5 
 
Shallo






























0 01 6 0 0 30 0 0 0.0 
02 6 0 0 
15 01 1 16 16,000 30 6 200 1.9 
02 1 17 17,000 
30 01 1 29 29,000 30 8 267 2.1 
02 1 32 32,000 
45 01 1 33 33,000 30 4 133 2.5 
02 1 57 57,000 
60 01 1 61 61,000 30 15 500 2.1 
02 1 60 60,000 
75 01 1 56 56,000 30 10 333 2.3 
02 1 69 69,000 
90 01 1 85 85,000 30 4 133 2.8 
02 1 82 82,000 
105 01 1 95 95,000 30 12 400 2.4 






























0 01 6 0 0 30 8 267 0.0 
02 6 0 0 
15 01 1 10 10,000 30 1 33 2.5 
02 1 9 9,000 
30 01 1 20 20,000 30 2 67 2.4 
02 1 17 17,000 
45 01 1 38 38,000 30 1.5 50 2.9 
02 1 34 34,000 
60 01 1 42 42,000 30 1 33 3.1 
02 1 44 44,000 
75 01 1 74 74,000 30 32 1,067 1.8 
02 1 75 75,000 
90 01 1 101 101,000 30 47 1,567 1.8 
02 1 90 90,000 
105 01 1 118 118,000 30 66 2,200 1.7 





Date: April 23, 2018 
ID: MID0-6 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 


















Shallow Harris regular (0.3) 0mg/L 5 1100L 
between  
5.00E+07 
Deep Harris deep (0.48) 0mg/L 5 
 
Shallo





























0 01 6 0 0 30 4 133 0.0 
02 6 17 2,833 
15 01 1 0 0 30 48 1,600 -- 
02 1 0 0 
30 01 1 23 23,000 30 57 1,900 1.0 
02 1 12 12,000 
45 01 1 42 42,000 30 59 1,967 1.3 
02 1 28 28,000 
60 01 1 59 59,000 30 175 5,833 1.0 
02 1 62 62,000 
75 01 1 73 73,000 30 153 5,100 1.2 
02 1 105 105,000 
90 01 1 112 112,000 30 187 6,233 1.3 
02 1 121 121,000 
105 01 1 159 159,000 30 87 2,900 1.7 






























0 01 6 0 0 30 118 3,933 0.0 
02 6 2 333 
15 01 1 11 11,000 30 79 2,633 0.3 
02 1 0 0 
30 01 1 25 25,000 30 151 5,033 0.4 
02 1 2 2,000 
45 01 1 42 42,000 30 45 1,500 1.3 
02 1 22 22,000 
60 01 1 91 91,000 30 303 10,100 1.0 
02 1 76 76,000 
75 01 1 49 49,000 30 382 12,733 0.8 
02 1 95 95,000 
90 01 1 99 99,000 30 373 12,433 0.9 
02 1 70 70,000 
105 01 1 133 133,000 30 381 12,700 0.9 





Date: May 29, 2018 
ID: END-1 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 1100L 
between  
6.90E+06 
Deep Harris deep (0.48) 40mg/L 5 
 
Shallo





























0 01 6 0 0 400 38 95 0.0 
02 6 11 1,833 
15 01 1 0 0 700 29 41 1.4 
02 1 2 2,000 
30 01 1 6 6,000 700 6 9 2.9 
02 1 6 6,000 
45 01 1 20 20,000 700 1 1 4.1 
02 1 15 15,000 
60 01 1 46 46,000 700 5 7 3.8 
02 1 50 50,000 
75 01 1 13 13,000 700 23 33 2.9 
02 1 37 37,000 
90 01 1 32 32,000 700 23 33 3.1 
02 1 59 59,000 
105 01 1 41 41,000 700 41 59 3.0 





Deep      


























0 01 6 5 833 700 0 0 0.0 
02 6 1 167 
15 01 1 0 0 700 23 33 1.2 
02 1 1 1,000 
30 01 1 14 14,000 700 28 40 2.6 
02 1 20 20,000 
45 01 1 12 12,000 700 7 10 3.2 
02 1 18 18,000 
60 01 1 44 44,000 700 28 40 3.0 
02 1 48 48,000 
75 01 1 37 36,500 700 10 14 3.4 
02 1 35 35,000 
90 01 1 74 74,000 700 8 11 3.8 
02 1 60 60,000 
105 01 1 78 78,000 700 10 14 3.8 





Date: November 13, 2017 
ID: SUR-1 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
4.75E+06 
Deep Harris deep (0.48) 40mg/L 5 
 
























0 01 6 1 167 700 0 0 0.0 
02 6 6 1,000 
50 01 1 55 55,000 700 6 9 3.9 
02 1 78 78,000 
55 01 1 53 53,000 700 1 1 4.6 
02 1 57 57,000 
61 01 1 123 123,000 700 1 1 4.7 
02 1 12 12,000 
66 01 1 92 92,000 700 8 11 3.9 
02 1 96 96,000 
71 01 1 91 91,000 700 6 9 4.0 
02 1 80 80,000 
80 01 1 88 88,000 700 1* 1 >4.6 
02 1 34 34,000 
100 01 1 61 61,000 700 1 1 4.6 
02 1 47 47,000 





























0 01 6 1 167 700 0 0 0.0 
02 6 0 0 
50 01 1 65 65,000 700 1* 1 >4.5 
02 1 17 17,000 
55 01 1 71 71,000 700 1* 1 >4.6 
02 1 38 38,000 
61 01 1 43 43,000 700 1 1 4.6 
02 1 83 83,000 
66 01 1 60 60,000 700 2 3 4.4 
02 1 71 71,000 
71 01 1 43 43,000 700 1* 1 >4.6 
02 1 72 72,000 
80 01 1 107 107,000 700 1* 1 >4.9 
02 1 108 108,000 
100 01 1 85 85,000 700 1 1 4.9 
02 1 119 119,000 





Date: November 28, 2017 
ID: SUR-2 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
3.03E+06 
Deep Harris deep (0.48) 40mg/L 5 
 
Shallo



























0 01 6 0 0 700 0 0 0.0 
02 6 2 333 
50 01 1 90 90,000 700 1 1 4.7 
02 1 58 58,000 
55 01 1 72 72,000 700 3 4 4.3 
02 1 81 81,000 
61 01 1 61 61,000 700 1 1 4.7 
02 1 82 82,000 
68 01 1 87 87,000 700 3 4 4.2 
02 1 59 59,000 
73 01 1 83 83,000 700 5 7 4.1 
02 1 105 105,000 
80 01 1 118 118,000 700 160 229 2.7 
02 1 96 96,000 
100 01 1 90 90,000 700 9 13 3.9 





























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
50 01 1 36 36,000 700 1 1 >4.6 
02 1 82 82,000 
55 01 1 87 87,000 700 1* 1 >4.7 
02 1 48 48,000 
61 01 1 48 48,000 700 TNTC TNTC TNTC 
02 1 74 74,000 
68 01 1 75 75,000 100 2 10 3.9 
02 1 85 85,000 700 0 
73 01 1 134 134,000 700 1 1 4.9 
02 1 97 97,000 
80 01 1 114 114,000 700 1 1 4.9 
02 1 121 121,000 
100 01 1 90 90,000 700 1 1 4.9 
02 1 110 110,000 
*actual slide count is 0 but changed to 1 to calculate a conservative oocyst removal 




Date: January 22, 2018 
ID: SUR-3 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
4.94E+06 
Deep Harris deep (0.48) 40mg/L 5 
 
























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
50 01 1 45 45,000 700 1* 1 >4.5 
02 1 53 53,000 
55 01 1 31 31,000 700 2 3 4.1 
02 1 39 39,000 
61 01 1 51 51,000 700 2 3 4.3 
02 1 60 60,000 
66 01 1 80 80,000 700 1 1 4.7 
02 1 76 76,000 
71 01 1 91 91,000 700 1 1 4.8 
02 1 83 83,000 
80 01 1 101 101,000 700 1 1 4.9 
02 1 140 140,000 
100 01 1 121 121,000 700 1 1 5.0 
02 1 177 177,000 






























0 01 6 0 0 700 0 0 0.0 
02 6 2 333 
50 01 1 71 71,000 700 1* 1 >4.6 
02 1 47 47,000 
55 01 1 42 42,000 700 1 1 4.7 
02 1 85 85,000 
61 01 1 78 78,000 700 1 1 4.7 
02 1 79 79,000 
66 01 1 92 92,000 700 2 3 4.5 
02 1 86 86,000 
71 01 1 111 111,000 700 1 1 4.9 
02 1 96 96,000 
80 01 1 171 171,000 700 2 3 4.7 
02 1 133 133,000 
100 01 1 331 331,000 700 2 3 4.9 
02 1 99 99,000 




Date: February 6, 2018 
ID: SUR-4 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
1.80E+06 
Deep Harris deep (0.48) 40mg/L 5 
 
Shallo



























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
50 01 1 42 42,000 700 2 3 4.2 
02 1 41 41,000 
55 01 1 50 50,000 700 2 3 4.2 
02 1 40 40,000 
61 01 1 65 65,000 700 3 4 4.2 
02 1 59 59,000 
66 01 1 80 80,000 700 3 4 4.3 
02 1 81 81,000 
71 01 1 72 72,000 700 3 4 4.2 
02 1 74 74,000 
80 01 1 79 79,000 700 4 6 4.1 
02 1 88 88,000 
100 01 1 90 90,000 700 5 7 4.1 






























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
50 01 1 25 25,000 700 1 1 4.3 
02 1 27 27,000 
55 01 1 31 31,000 700 1 1 4.4 
02 1 39 39,000 
61 01 1 103 103,000 700 1 1 4.9 
02 1 101 101,000 
66 01 1 55 55,000 700 2 3 4.3 
02 1 59 59,000 
71 01 1 101 101,000 700 1 1 4.9 
02 1 102 102,000 
80 01 1 145 145,000 700 2 3 4.6 
02 1 93 93,000 
100 01 1 187 187,000 700 3 4 4.6 





Date: February 21, 2018 
ID: SUR-5 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 
C. parvum Oocyst Removal CAF of High Quality Source Water 
 
Filter Plant 














Shallow Harris regular (0.3) 40mg/L 5 1050mL 
between  
3.90E+07 
Deep Harris deep (0.48) 40mg/L 5 
 
Shallo



























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
50 01 1 59 59,000 700 9 13 3.7 
02 1 61 61,000 
55 01 1 38 38,000 700 1 1 4.4 
02 1 43 43,000 
61 01 1 156 156,000 700 2 3 4.7 
02 1 115 115,000 
66 01 1 162 162,000 700 2 3 4.7 
02 1 132 132,000 
71 01 1 108 108,000 700 2 3 4.6 
02 1 113 113,000 
80 01 1 121 121,000 700 4 6 4.3 
02 1 117 117,000 
100 01 1 92 92,000 700 2 3 4.5 






























0 01 6 0 0 700 0 0 0.0 
02 6 0 0 
50 01 1 74 74,000 700 1* 1 >4.7 
02 1 71 71,000 
55 01 1 82 82,000 700 1 1 4.8 
02 1 86 86,000 
61 01 1 144 144,000 700 1 1 4.9 
02 1 104 104,000 
66 01 1 134 134,000 700 2 3 4.6 
02 1 110 110,000 
71 01 1 125 125,000 700 2 3 4.6 
02 1 119 119,000 
80 01 1 113 113,000 700 1 1 4.9 
02 1 138 138,000 
100 01 1 152 152,000 700 1 1 5.0 
02 1 110 110,000 





Date: June 19, 2018 
ID: SUR-6 
Type of Experiment: Phase 2 - Pilot-scale Evaluation of Filter Design and Operational Effects on 


















Shallow Harris regular (0.3) 40mg/L 5 1080L 
between  
4.42E+07 
Deep Harris deep (0.48) 40mg/L 5 
 






























0 01 6 0 0 700 4 6 0.0 
02 6 6 1,000 
50 01 1 31 31,000 700 27 39 2.9 
02 1 31 31,000 
55 01 1 33 33,000 700 17 24 3.1 
02 1 32 32,000 
67 01 1 40 40,000 700 9 13 3.6 
02 1 72 72,000 
72 01 1 73 73,000 700 27 39 3.1 
02 1 33 33,000 
77 01 1 43 43,000 700 51 73 2.9 
02 1 72 72,000 
86 01 1 52 52,000 700 26 37 3.1 
02 1 48 48,000 
106 01 1 76 76,000 700 20 29 3.4 





Deep      

























0 01 6 0 0 700 134 191 0.0 
02 6 0 0 
50 01 1 28 28,000 700 12 17 3.3 
02 1 33 33,000 
55 01 1 35 35,000 700 11 16 3.4 
02 1 44 44,000 
67 01 1 16 16,000 700 6 9 3.6 
02 1 48 48,000 
72 01 1 33 33,000 700 92 131 2.5 
02 1 49 49,000 
77 01 1 33 33,000 700 5 7 3.9 
02 1 73 73,000 
86 01 1 57 57,000 700 14 20 3.6 
02 1 96 96,000 
106 01 1 90 90,000 700 10 14 3.8 
02 1 80 80,000 
 
 
 
 
 
